RCW 69.06.020 — Washington Code / Title 69 / Chapter 06 / Section 020
RCW 69.06.020: Permit exclusive and valid throughout state—Fee.
Status: in_force

The permit provided in RCW 69.06.010 or 69.06.070 shall be valid in every city, town and county in the state, for the period for which it is issued, and no other health certificate shall be required of such employees by any municipal corporation or political subdivision of the state. The cost of the permit shall be uniform throughout the state and shall be in that amount set by the state board of health. The cost of the permit shall reflect actual costs of food worker training and education, administration of the program, and testing of applicants. The state board of health shall periodically review the costs associated with the permit program and adjust the fee accordingly. The board shall also ensure that the fee is not set at an amount that would prohibit low-income persons from obtaining permits.
RCW 69.52.060 — Washington Code / Title 69 / Chapter 52 / Section 060
RCW 69.52.060: Injunctive or other legal action by manufacturer of controlled substances authorized.
Status: in_force

Any manufacturer of controlled substances licensed or registered in a state requiring such licensure or registration, may bring injunctive or other action against a manufacturer or distributor of imitation controlled substances in this state.
RCW 69.28.110 — Washington Code / Title 69 / Chapter 28 / Section 110
RCW 69.28.110: Use of used containers.
Status: in_force

It shall be unlawful to sell, offer, or expose for sale to the consumer any honey in any secondhand or used containers which formerly contained honey, unless all markings as to grade, name and weight have been obliterated, removed or erased.
RCW 69.45.070 — Washington Code / Title 69 / Chapter 45 / Section 070
RCW 69.45.070: Registration fees—Penalty.
Status: in_force

The department may charge reasonable fees for registration. The registration fee shall not exceed the fee charged by the department for a pharmacy location license. If the registration fee is not paid on or before the date due, a renewal or new registration may be issued only upon payment of the registration renewal fee and a penalty fee equal to the registration renewal fee.
RCW 69.45.030 — Washington Code / Title 69 / Chapter 45 / Section 030
RCW 69.45.030: Records maintained by manufacturer—Report of loss or theft of drug samples—Reports of practitioners receiving controlled substance drug samples.
Status: in_force

(1) The following records shall be maintained by the manufacturer distributing drug samples in this state and shall be available for inspection by authorized representatives of the department based on reasonable cause and pursuant to an official investigation: (a) An inventory of drug samples held in this state for distribution, taken at least annually by a representative of the manufacturer other than the individual in direct control of the drug samples; (b) Records or documents to account for all drug samples distributed, destroyed, or returned to the manufacturer. The records shall include records for sample drugs signed for by practitioners, dates and methods of destruction, and any dates of returns; and (c) Copies of all reports of lost or stolen drug samples. (2) All required records shall be maintained for two years and shall include transaction dates. (3) Manufacturers shall report to the department the discovery of any loss or theft of drug samples as soon as possible but not later than the close of business on the next business day following the discovery. (4) Manufacturers shall report to the department as frequently as, and at the same time as, their other reports to the federal drug enforcement administration, or its lawful successor, the name, address and federal registration number for each practitioner who has received controlled substance drug samples and the name, strength and quantity of the controlled substance drug samples distributed.
RCW 69.51A.050 — Washington Code / Title 69 / Chapter 51A / Section 050
RCW 69.51A.050: Medical cannabis, lawful possession—State not liable.
Status: in_force

(1) The lawful possession or manufacture of medical cannabis as authorized by this chapter shall not result in the forfeiture or seizure of any property. (2) No person shall be prosecuted for constructive possession, conspiracy, or any other criminal offense solely for being in the presence or vicinity of medical cannabis or its use as authorized by this chapter. (3) The state shall not be held liable for any deleterious outcomes from the medical use of cannabis by any qualifying patient.
RCW 69.04.160 — Washington Code / Title 69 / Chapter 04 / Section 160
RCW 69.04.160: Prosecutions.
Status: in_force

(1) It shall be the duty of each state attorney, county attorney, or city attorney to whom the director reports any violation of this chapter, or regulations promulgated under it, to cause appropriate proceedings to be instituted in the proper courts, without delay, and to be duly prosecuted as prescribed by law. (2) Before any violation of this chapter is reported by the director to any such attorney for the institution of a criminal proceeding, the person against whom such proceeding is contemplated shall be given appropriate notice and an opportunity to present his or her views to the director, either orally or in writing, with regard to such contemplated proceeding.
RCW 69.50.3251 — Washington Code / Title 69 / Chapter 50 / Section 3251
RCW 69.50.3251: Cannabis manufacture, sale, distribution prohibited without a license—Tribal agreements—Synthetic cannabinoids prohibited.
Status: in_force

(1) Except as otherwise provided in this chapter or as permitted under an agreement between the state and a tribe entered into under RCW 43.06.490 , no person may manufacture, sell, or distribute cannabis, cannabis concentrates, useable cannabis, or cannabis-infused products, or any cannabis products without a valid license issued by the board or commission. (2) Except as permitted under an agreement between the state and a tribe entered into under RCW 43.06.490 , any person performing any act requiring a license under this title, without having in force an appropriate and valid license issued to the person, is in violation of this chapter. (3) The producing, processing, manufacturing, or sale of any synthetically derived, or completely synthetic, cannabinoid is prohibited, except for products approved by the United States food and drug administration.
RCW 69.50.438 — Washington Code / Title 69 / Chapter 50 / Section 438
RCW 69.50.438: Cathinone or methcathinone—Additional fine.
Status: in_force

In addition to any other civil or criminal penalty, every person who violates or causes another to violate RCW 69.50.401 by distributing, dispensing, manufacturing, displaying for sale, offering for sale, attempting to sell, or selling to a purchaser any product that contains any amount of any cathinone or methcathinone, as identified in RCW 69.50.204 , must be fined not less than ten thousand dollars and not more than five hundred thousand dollars. If, however, the person who violates or causes another to violate RCW 69.50.401 by distributing, dispensing, manufacturing, displaying for sale, offering for sale, attempting to sell, or selling any product that contains any amount of any cathinone or methcathinone, as identified in RCW 69.50.204 , to a purchaser under the age of eighteen, the minimum penalty is twenty-five thousand dollars if the person is at least two years older than the minor. Unless the court finds the person to be indigent, this additional fine may not be suspended or deferred by the court.
RCW 69.28.240 — Washington Code / Title 69 / Chapter 28 / Section 240
RCW 69.28.240: "Pack," "packing," or "packed" defined.
Status: in_force

The term "pack", "packing", or "packed" shall mean the arrangement of all or part of the subcontainers in any container.
RCW 69.50.375 — Washington Code / Title 69 / Chapter 50 / Section 375
RCW 69.50.375: Cannabis retailers—Medical cannabis endorsement.
Status: in_force

(1) A medical cannabis endorsement to a cannabis retail license is hereby established to permit a cannabis retailer to sell cannabis for medical use to qualifying patients and designated providers. This endorsement also permits such retailers to provide cannabis at no charge, at their discretion, to qualifying patients and designated providers. (2) An applicant may apply for a medical cannabis endorsement concurrently with an application for a cannabis retail license. (3) To be issued an endorsement, a cannabis retailer must: (a) Not authorize the medical use of cannabis for qualifying patients at the retail outlet or permit health care professionals to authorize the medical use of cannabis for qualifying patients at the retail outlet; (b) Carry cannabis concentrates and cannabis-infused products identified by the department under subsection (4) of this section; (c) Not use labels or market cannabis concentrates, useable cannabis, or cannabis-infused products in a way that make them intentionally attractive to minors; (d) Demonstrate the ability to enter qualifying patients and designated providers in the medical cannabis authorization database established in RCW 69.51A.230 and issue recognition cards and agree to enter qualifying patients and designated providers into the database and issue recognition cards in compliance with department standards; (e) Keep copies of the qualifying patient's or designated provider's recognition card, or keep equivalent records as required by rule of the board or the department of revenue to document the validity of tax exempt sales; and (f) Meet other requirements as adopted by rule of the department or the board. (4) The department, in conjunction with the board, must adopt rules on requirements for cannabis concentrates, useable cannabis, and cannabis-infused products that may be sold, or provided at no charge, to qualifying patients or designated providers at a retail outlet holding a medical cannabis endorsement. These rules must include: (a) THC concentration, CBD concentration, or low THC, high CBD ratios appropriate for cannabis concentrates, useable cannabis, or cannabis-infused products sold to qualifying patients or designated providers; (b) Labeling requirements including that the labels attached to cannabis concentrates, useable cannabis, or cannabis-infused products contain THC concentration, CBD concentration, and THC to CBD ratios; (c) Other product requirements, including any additional mold, fungus, or pesticide testing requirements, or limitations to the types of solvents that may be used in cannabis processing that the department deems necessary to address the medical needs of qualifying patients; (d) Safe handling requirements for cannabis concentrates, useable cannabis, or cannabis-infused products; and (e) Training requirements for employees. (5) A cannabis retailer holding an endorsement to sell cannabis to qualifying patients or designated providers must train its employees on: (a) Procedures regarding the recognition of valid authorizations and the use of equipment to enter qualifying patients and designated providers into the medical cannabis authorization database; (b) Recognition of valid recognition cards; and (c) Recognition of strains, varieties, THC concentration, CBD concentration, and THC to CBD ratios of cannabis concentrates, useable cannabis, and cannabis-infused products, available for sale when assisting qualifying patients and designated providers at the retail outlet.
RCW 69.40.055 — Washington Code / Title 69 / Chapter 40 / Section 055
RCW 69.40.055: Selling repackaged poison without labeling—Penalty.
Status: in_force

It shall be unlawful for any person to sell at retail or furnish any repackaged poison drug or product without affixing or causing to be affixed to the bottle, box, vessel, or package a label containing the name of the article, all labeling required by the Food and Drug Administration and other federal or state laws or regulations, and the word "poison" distinctly shown with the name and place of the business of the seller. This section shall not apply to the dispensing of drugs or poisons on the prescription of a practitioner. The pharmacy quality assurance commission shall have the authority to promulgate rules for the enforcement and implementation of this section. Every person who shall violate any of the provisions of this section shall be guilty of a misdemeanor.
RCW 69.22.020 — Washington Code / Title 69 / Chapter 22 / Section 020
RCW 69.22.020: Requirements—Authority of director.
Status: in_force

(1) The director may adopt, by rule, requirements for cottage food operations. These requirements may include, but are not limited to: (a) The application and renewal of permits under RCW 69.22.030 ; (b) Inspections as provided under RCW 69.22.040 ; (c) Sanitary procedures; (d) Facility, equipment, and utensil requirements; (e) Labeling specificity beyond the requirements of this section; (f) Requirements for clean water sources and waste and wastewater disposal; and (g) Requirements for washing and other hygienic practices. (2) A cottage food operation must package and properly label for sale to the consumer any food it produces, and the food may not be repackaged, sold, or used as an ingredient in other foods by a food processing plant, or sold by a food service establishment. (3) A cottage food operation must place on the label of any food it produces or packages, at a minimum, the following information: (a) The name and permit number issued under RCW 69.22.030 of the business of the cottage food operation; (b) The name of the cottage food product; (c) The ingredients of the cottage food product, in descending order of predominance by weight; (d) The net weight or net volume of the cottage food product; (e) Allergen labeling as specified by the director in rule; (f) If any nutritional claim is made, appropriate labeling as specified by the director in rule; (g) The following statement printed in at least the equivalent of eleven-point font size in a color that provides a clear contrast to the background: "Made in a home kitchen that has not been subject to standard inspection criteria." (4) Cottage food products may only be sold directly to the consumer and may not be sold by internet, mail order, or for retail sale outside the state. (5) Cottage food products must be stored only in the primary domestic residence.
RCW 69.28.410 — Washington Code / Title 69 / Chapter 28 / Section 410
RCW 69.28.410: Embargo on honey or product—Notice by director—Removal.
Status: in_force

Whenever the director shall find, or shall have probable cause to believe, that any honey or product subject to the provisions of this chapter, as now or hereafter amended, is in intrastate commerce, which was introduced into such intrastate commerce in violation of the provisions of this chapter, as now or hereafter amended, he or she is hereby authorized to affix to such honey or product a notice placing an embargo on such honey or product, and prohibiting its sale in intrastate commerce, and no person shall move or sell such honey or product without first receiving permission from the director to move or sell such honey or product. But if, after such honey or product has been embargoed, the director shall find that such honey or product does not involve a violation of this chapter, as now or hereafter amended, such embargo shall be forthwith removed.
RCW 69.04.012 — Washington Code / Title 69 / Chapter 04 / Section 012
RCW 69.04.012: "Official compendium."
Status: in_force

The term "official compendium" mean the official United States pharmacopoeia, official homeopathic pharmacopoeia of the United States, official national formulary, or any supplement to any of them.
RCW 69.28.180 — Washington Code / Title 69 / Chapter 28 / Section 180
RCW 69.28.180: Violation of rules and regulations unlawful.
Status: in_force

It shall be unlawful for any person to violate any rule or regulation promulgated by the director under the provisions of this chapter.
RCW 69.50.3255 — Washington Code / Title 69 / Chapter 50 / Section 3255
RCW 69.50.3255: Cannabis producers and processors—Cannabis waste.
Status: in_force

(1) A licensed cannabis producer and a licensed cannabis processor may sell cannabis waste to a person not licensed under this chapter if: (a) The cannabis waste would not be designated as dangerous or hazardous waste under: (i) Chapter 70A.300 RCW and rules adopted under that chapter; and (ii) Cannabis waste disposal rules adopted by the board; (b) The licensee notifies the board and the Washington state department of agriculture before the sale. Such notice must include information about the quantity and sale price of cannabis waste transferred and the name of the person or entity that purchased the cannabis waste; and (c) The licensee makes all sales available to the public on an equal and nondiscriminatory basis. (2) Cannabis waste not sold in accordance with subsection (1) of this section and not designated as dangerous or hazardous waste under chapter 70A.300 RCW, rules adopted pursuant to that chapter, or cannabis waste disposal rules adopted by the board must be rendered unusable before leaving a licensed producer, processor, or laboratory. (3) For the purposes of this section, "cannabis waste" means solid waste generated during cannabis production or processing that has a THC concentration of 0.3 percent or less. "Cannabis waste" does not include "hemp" or "industrial hemp" as those terms are defined in RCW 15.140.020 . (4) Nothing in this chapter prohibits producers or processors from selling cannabis waste to a person not licensed under this chapter if such transfer is pursuant to the requirements of this section. (5) The board may adopt rules necessary to implement this section.
RCW 69.50.414 — Washington Code / Title 69 / Chapter 50 / Section 414
RCW 69.50.414: Sale or transfer of controlled substance to minor—Cause of action by parent—Damages.
Status: in_force

The parent or legal guardian of any minor to whom a controlled substance, as defined in RCW 69.50.101 , is sold or transferred, shall have a cause of action against the person who sold or transferred the controlled substance for all damages to the minor or his or her parent or legal guardian caused by such sale or transfer. Damages shall include: (a) [(1)] Actual damages, including the cost for treatment or rehabilitation of the minor child's drug dependency, (b) [(2)] forfeiture to the parent or legal guardian of the cash value of any proceeds received from such sale or transfer of a controlled substance, and (c) [(3)] reasonable attorney fees. This section shall not apply to a practitioner, as defined in RCW 69.50.101 , who sells or transfers a controlled substance to a minor pursuant to a valid prescription or order.
RCW 69.41.065 — Washington Code / Title 69 / Chapter 41 / Section 065
RCW 69.41.065: Violations—Juvenile driving privileges.
Status: in_force

(1) If a juvenile thirteen years of age or older and under the age of twenty-one is found by a court to have committed any offense that is a violation of this chapter, the court shall notify the department of licensing within twenty-four hours after entry of the judgment, unless the offense is the juvenile's first offense in violation of this chapter and has not committed an offense while armed with a firearm, an unlawful possession of a firearm offense, or an offense in violation of chapter 66.44 , 69.50, or 69.52 RCW. (2) Except as otherwise provided in subsection (3) of this section, upon petition of a juvenile whose privilege to drive has been revoked pursuant to RCW 46.20.265 , the court may notify the department of licensing that the juvenile's privilege to drive should be reinstated. (3) If the conviction is for the juvenile's first violation of this chapter or chapter 66.44 , 69.50, or 69.52 RCW, the juvenile may not petition the court for reinstatement of the juvenile's privilege to drive revoked pursuant to RCW 46.20.265 until the later of ninety days after the date the juvenile turns sixteen or ninety days after the judgment was entered. If the conviction was for the juvenile's second or subsequent violation of this chapter or chapter 66.44 , 69.50, or 69.52 RCW, the juvenile may not petition the court for reinstatement of the juvenile's privilege to drive revoked pursuant to RCW 46.20.265 until the later of the date the juvenile turns seventeen or one year after the date judgment was entered.
RCW 69.04.780 — Washington Code / Title 69 / Chapter 04 / Section 780
RCW 69.04.780: Investigations—Samples—Right of entry—Verified statements.
Status: in_force

The director shall cause the investigation and examination of food, drugs, devices, and cosmetics subject to this chapter. The director shall have the right (1) to take a sample or specimen of any such article, for examination under this chapter, upon tendering the market price therefor to the person having such article in custody; and (2) to enter any place or establishment within this state, at reasonable times, for the purpose of taking a sample or specimen of any such article, for such examination. The director and the director's deputies, assistants, and inspectors are authorized to do all acts and things necessary to carry out the provisions of this chapter, including the taking of verified statements. Such department personnel are empowered to administer oaths of verification on the statements.
RCW 69.25.900 — Washington Code / Title 69 / Chapter 25 / Section 900
RCW 69.25.900: Savings.
Status: in_force

The enactment of this chapter shall not have the effect of terminating or in any way modifying any liability, civil or criminal, which shall already be in existence on July 1, 1975.
RCW 69.45.085 — Washington Code / Title 69 / Chapter 45 / Section 085
RCW 69.45.085: Uniform disciplinary act.
Status: in_force

The uniform disciplinary act, chapter 18.130 RCW, governs unlicensed practice of persons required to obtain a registration under this chapter.
RCW 69.50.102 — Washington Code / Title 69 / Chapter 50 / Section 102
RCW 69.50.102: Drug paraphernalia—Definitions.
Status: in_force

(a) [(1)] As used in this chapter, "drug paraphernalia" means all equipment, products, and materials of any kind which are used, intended for use, or designed for use in planting, propagating, cultivating, growing, harvesting, manufacturing, compounding, converting, producing, processing, preparing, testing, analyzing, packaging, repackaging, storing, containing, concealing, injecting, ingesting, inhaling, or otherwise introducing into the human body a controlled substance. It includes, but is not limited to: (1) [(a)] Kits used, intended for use, or designed for use in planting, propagating, cultivating, growing, or harvesting of any species of plant which is a controlled substance or from which a controlled substance can be derived; (2) [(b)] Kits used, intended for use, or designed for use in manufacturing, compounding, converting, producing, processing, or preparing controlled substances; (3) [(c)] Isomerization devices used, intended for use, or designed for use in increasing the potency of any species of plant which is a controlled substance; (4) [(d)] Testing equipment used, intended for use, or designed for use in identifying or in analyzing the strength, effectiveness, or purity of controlled substances; (5) [(e)] Scales and balances used, intended for use, or designed for use in weighing or measuring controlled substances; (6) [(f)] Diluents and adulterants, such as quinine hydrochloride, mannitol, mannite, dextrose, and lactose, used, intended for use, or designed for use in cutting controlled substances; (7) [(g)] Separation gins and sifters used, intended for use, or designed for use in removing twigs and seeds from, or in otherwise cleaning or refining, cannabis; (8) [(h)] Blenders, bowls, containers, spoons, and mixing devices used, intended for use, or designed for use in compounding controlled substances; (9) [(i)] Capsules, balloons, envelopes, and other containers used, intended for use, or designed for use in packaging small quantities of controlled substances; (10) [(j)] Containers and other objects used, intended for use, or designed for use in storing or concealing controlled substances; (11) [(k)] Hypodermic syringes, needles, and other objects used, intended for use, or designed for use in parenterally injecting controlled substances into the human body; (12) [(l)] Objects used, intended for use, or designed for use in ingesting, inhaling, or otherwise introducing cannabis, cocaine, hashish, or hashish oil into the human body, such as: (i) Metal, wooden, acrylic, glass, stone, plastic, or ceramic pipes with or without screens, permanent screens, hashish heads, or punctured metal bowls; (ii) Water pipes; (iii) Carburetion tubes and devices; (iv) Smoking and carburetion masks; (v) Roach clips: Meaning objects used to hold burning material, such as a cannabis cigarette, that has become too small or too short to be held in the hand; (vi) Miniature cocaine spoons, and cocaine vials; (vii) Chamber pipes; (viii) Carburetor pipes; (ix) Electric pipes; (x) Air-driven pipes; (xi) Chillums; (xii) Bongs; and (xiii) Ice pipes or chillers. (b) [(2)] In determining whether an object is drug paraphernalia under this section, a court or other authority should consider, in addition to all other logically relevant factors, the following: (1) [(a)] Statements by an owner or by anyone in control of the object concerning its use; (2) [(b)] Prior convictions, if any, of an owner, or of anyone in control of the object, under any state or federal law relating to any controlled substance; (3) [(c)] The proximity of the object, in time and space, to a direct violation of this chapter; (4) [(d)] The proximity of the object to controlled substances; (5) [(e)] The existence of any residue of controlled substances on the object; (6) [(f)] Direct or circumstantial evidence of the intent of an owner, or of anyone in control of the object, to deliver it to persons whom he or she knows, or should reasonably know, intend to use the object to facilitate a violation of this chapter; the innocence of an owner, or of anyone in control of the object, as to a direct violation of this chapter shall not prevent a finding that the object is intended or designed for use as drug paraphernalia; (7) [(g)] Instructions, oral or written, provided with the object concerning its use; (8) [(h)] Descriptive materials accompanying the object which explain or depict its use; (9) [(i)] National and local advertising concerning its use; (10) [(j)] The manner in which the object is displayed for sale; (11) [(k)] Whether the owner, or anyone in control of the object, is a legitimate supplier of like or related items to the community, such as a licensed distributor or dealer of tobacco products; (12) [(l)] Direct or circumstantial evidence of the ratio of sales of the object(s) to the total sales of the business enterprise; (13) [(m)] The existence and scope of legitimate uses for the object in the community; and (14) [(n)] Expert testimony concerning its use.
RCW 69.43.070 — Washington Code / Title 69 / Chapter 43 / Section 070
RCW 69.43.070: Sale, transfer, or furnishing of substance for unlawful purpose—Receipt of substance with intent to use unlawfully—Class B felony.
Status: in_force

(1) Any manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes any substance listed in RCW 69.43.010 with knowledge or the intent that the recipient will use the substance unlawfully to manufacture a controlled substance under chapter 69.50 RCW is guilty of a class B felony under chapter 9A.20 RCW. (2) Any person who receives any substance listed in RCW 69.43.010 with intent to use the substance unlawfully to manufacture a controlled substance under chapter 69.50 RCW is guilty of a class B felony under chapter 9A.20 RCW.
RCW 69.77.050 — Washington Code / Title 69 / Chapter 77 / Section 050
RCW 69.77.050: Informed consent.
Status: in_force

(1) Prior to treatment of the eligible patient with an investigational product, the treating physician shall obtain written informed consent, consistent with the requirements of RCW 7.70.060 (1), and signed by the eligible patient or, if the patient lacks the capacity to consent, his or her legally authorized representative. (2) Information provided in order to obtain the informed consent must, to the extent possible, include the following: (a) That the patient has been diagnosed with a serious or immediately life-threatening disease or condition and explains the currently approved products and treatments for the disease or condition from which the eligible patient suffers; (b) That all currently approved and conventionally recognized treatments are unlikely to prolong the eligible patient's life; (c) Clear identification of the investigational product that the eligible patient seeks to use; (d) The potentially best and worst outcomes of using the investigational product and a realistic description of the most likely outcome. This description must include the possibility that new, unanticipated, different, or worse symptoms may result and that death could be hastened by the proposed treatment. The description must be based on the physician's knowledge of the proposed treatment in conjunction with an awareness of the eligible patient's condition; (e) That the eligible patient's health benefit plan is not obligated to pay for the investigational product or any harm caused to the eligible patient by the investigational product, unless otherwise specifically required to do so by law or contract, and that in order to receive the investigational product the patient may be required to pay the costs of administering the investigational product; and (f) That the eligible patient is liable for all expenses consequent to the use of the investigational product, except as otherwise provided in the eligible patient's health benefit plan or a contract between the eligible patient and the manufacturer of the investigational product. (3) The document must be signed and dated by the eligible patient's treating physician and witnessed in writing by at least one adult.
RCW 69.80.050 — Washington Code / Title 69 / Chapter 80 / Section 050
RCW 69.80.050: Inspection of donated food by state and local agencies—Variance.
Status: in_force

(1) Appropriate state and local agencies are authorized to inspect donated food items for wholesomeness and may establish procedures for the handling of food items. (2) To facilitate the free distribution of food to needy persons, the local health officer, upon request from either a donor or distributing organization, may grant a variance to chapter 246-215 WAC covering physical facilities, equipment standards, and food source requirements when no known or expected health hazard would exist as a result of the action.
RCW 69.50.205 — Washington Code / Title 69 / Chapter 50 / Section 205
RCW 69.50.205: Schedule II tests.
Status: in_force

(a) [(1)] The commission shall place a substance in Schedule II upon finding that: (1) [(a)] the substance has high potential for abuse; (2) [(b)] the substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and (3) [(c)] the abuse of the substance may lead to severe psychological or physical dependence. (b) [(2)] The commission may place a substance in Schedule II without making the findings required by subsection (a) [(1)] of this section if the substance is controlled under Schedule II of the federal Controlled Substances Act by a federal agency as the result of an international treaty, convention, or protocol.
RCW 69.50.601 — Washington Code / Title 69 / Chapter 50 / Section 601
RCW 69.50.601: Pending proceedings.
Status: in_force

(a) [(1)] Prosecution for any violation of law occurring prior to May 21, 1971 is not affected or abated by this chapter. If the offense being prosecuted is similar to one set out in Article IV of this chapter, then the penalties under Article IV apply if they are less than those under prior law. (b) [(2)] Civil seizures or forfeitures and injunctive proceedings commenced prior to May 21, 1971 are not affected by this chapter. (c) [(3)] All administrative proceedings pending under prior laws which are superseded by this chapter shall be continued and brought to a final determination in accord with the laws and rules in effect prior to May 21, 1971. Any substance controlled under prior law which is not listed within Schedules I through V, is automatically controlled without further proceedings and shall be listed in the appropriate schedule. (d) [(4)] The commission shall initially permit persons to register who own or operate any establishment engaged in the manufacture, distribution, or dispensing of any controlled substance prior to May 21, 1971 and who are registered or licensed by the state. (e) [(5)] This chapter applies to violations of law, seizures and forfeiture, injunctive proceedings, administrative proceedings and investigations which occur following May 21, 1971.
RCW 69.04.565 — Washington Code / Title 69 / Chapter 04 / Section 565
RCW 69.04.565: DMSO (dimethyl sulfoxide) authorized.
Status: in_force

Notwithstanding any other provision of state law, DMSO (dimethyl sulfoxide) may be introduced into intrastate commerce as long as (1) it is manufactured or distributed by persons licensed pursuant to chapter 18.64 RCW or chapter 18.92 RCW, and (2) it is used, or intended to be used, in the treatment of human beings or animals for any ailment or adverse condition: PROVIDED, That DMSO intended for topical application, consistent with rules governing purity and labeling promulgated by the pharmacy quality assurance commission, shall not be considered a legend drug and may be sold by any retailer.
RCW 69.50.612 — Washington Code / Title 69 / Chapter 50 / Section 612
RCW 69.50.612: State preemption—Drug paraphernalia.
Status: repealed

(1) The state of Washington hereby fully occupies and preempts the entire field of drug paraphernalia regulation within the boundaries of the state including regulation of the use, selling, giving, delivery, and possession of drug paraphernalia, except as provided in subsection (2) of this section. Cities, towns, and counties or other municipalities may enact only those laws and ordinances relating to drug paraphernalia that are specifically authorized by state law and are consistent with this chapter. Such local ordinances must have the same penalty as provided for by state law. Local laws and ordinances that are inconsistent with, more restrictive than, or exceed the requirements of state law may not be enacted and are preempted and repealed, regardless of the nature of the code, charter, or home rule status of such city, town, county, or municipality. (2) Nothing in this chapter shall be construed to prohibit cities or counties from enacting laws or ordinances relating to the establishment or regulation of harm reduction services concerning drug paraphernalia.
RCW 69.43.180 — Washington Code / Title 69 / Chapter 43 / Section 180
RCW 69.43.180: Expansion of log requirements—Petition by law enforcement.
Status: in_force

(1) The Washington association of sheriffs and police chiefs or the Washington state patrol may petition the pharmacy quality assurance commission to apply the log requirements in *RCW 69.43.170 to one or more products that contain ephedrine, pseudoephedrine, or phenylpropanolamine, or their salts, isomers, or salts of isomers, that is not the only active ingredient and that is in liquid, liquid capsule, or gel capsule form. The petition shall establish that: (a) Ephedrine, pseudoephedrine, or phenylpropanolamine can be effectively extracted from the product and converted into methamphetamine or another controlled dangerous substance; and (b) Law enforcement, the Washington state patrol, or the department of ecology are finding substantial evidence that the product is being used for the illegal manufacture of methamphetamine or another controlled dangerous substance. (2) The pharmacy quality assurance commission shall adopt rules when a petition establishes that requiring the application of the log requirements in *RCW 69.43.170 to the sale of the product at retail is warranted based upon the effectiveness and extent of use of the product for the illegal manufacture of methamphetamine or other controlled dangerous substances and the extent of the burden of any restrictions upon consumers. The pharmacy quality assurance commission may adopt emergency rules to apply the log requirements to the sale of a product when the petition establishes that the immediate restriction of the product is necessary in order to protect public health and safety.
RCW 69.28.230 — Washington Code / Title 69 / Chapter 28 / Section 230
RCW 69.28.230: "Clean and sound containers" defined.
Status: in_force

The term "clean and sound containers" shall mean containers which are virtually free from rust, stains or leaks.
RCW 69.43.120 — Washington Code / Title 69 / Chapter 43 / Section 120
RCW 69.43.120: Ephedrine, pseudoephedrine, phenylpropanolamine—Possession of more than fifteen grams—Penalty—Exceptions.
Status: in_force

(1) Any person who possesses more than fifteen grams of ephedrine, pseudoephedrine, or phenylpropanolamine, their salts, isomers, or salts of isomers, or a combination of any of those substances, is guilty of a gross misdemeanor. (2) This section does not apply to any of the following: (a) A pharmacist or other authorized person who sells or furnishes ephedrine, pseudoephedrine, or phenylpropanolamine, their salts, isomers, or salts of isomers upon the prescription of a practitioner, as defined in RCW 69.41.010 ; (b) A practitioner who administers or furnishes ephedrine, pseudoephedrine, or phenylpropanolamine, their salts, isomers, or salts of isomers to his or her patients; (c) A pharmacy, manufacturer, or wholesaler licensed by, or shopkeeper or itinerant vendor registered with, the department of health under chapter 18.64 RCW; (d) A person in the course of his or her business of selling, transporting, or storing ephedrine, pseudoephedrine, or phenylpropanolamine, their salts, isomers, or salts of isomers, for a person described in (a), (b), or (c) of this subsection; or (e) A person in possession of more than fifteen grams of ephedrine, pseudoephedrine, or phenylpropanolamine, their salts, isomers, or salts of isomers in their home or residence under circumstances consistent with typical medicinal or household use as indicated by, but not limited to, storage location and possession of products in a variety of strengths, brands, types, purposes, and expiration dates.
RCW 69.41.125 — Washington Code / Title 69 / Chapter 41 / Section 125
RCW 69.41.125: Interchangeable biological product may be substituted for biological product—Exception—Wholesale price less.
Status: in_force

Unless the prescribed biological product is requested by the patient or the patient's representative, if "substitution permitted" is marked on the prescription as provided in RCW 69.41.120 , the pharmacist must substitute an interchangeable biological product that he or she has in stock for the biological product prescribed if the wholesale price for the interchangeable biological product to the pharmacist is less than the wholesale price for the biological product prescribed.
RCW 69.52.020 — Washington Code / Title 69 / Chapter 52 / Section 020
RCW 69.52.020: Definitions.
Status: in_force

Unless the context clearly requires otherwise, the definitions in this section apply throughout this chapter. (1) "Controlled substance" means a substance as that term is defined in chapter 69.50 RCW. (2) "Distribute" means the actual or constructive transfer (or attempted transfer) or delivery or dispensing to another of an imitation controlled substance. (3) "Imitation controlled substance" means a substance that is not a controlled substance, but which by appearance or representation would lead a reasonable person to believe that the substance is a controlled substance. Appearance includes, but is not limited to, color, shape, size, and markings of the dosage unit. Representation includes, but is not limited to, representations or factors of the following nature: (a) Statements made by an owner or by anyone else in control of the substance concerning the nature of the substance, or its use or effect; (b) Statements made to the recipient that the substance may be resold for inordinate profit; or (c) Whether the substance is packaged in a manner normally used for illicit controlled substances. (4) "Manufacture" means the production, preparation, compounding, processing, encapsulating, packaging or repackaging, or labeling or relabeling of an imitation controlled substance.
RCW 69.50.710 — Washington Code / Title 69 / Chapter 50 / Section 710
RCW 69.50.710: Federal law—"Marijuana" to refer to "cannabis."
Status: in_force

The term "marijuana" as used under federal law generally refers to the term "cannabis" used throughout the Revised Code of Washington.
RCW 69.41.095 — Washington Code / Title 69 / Chapter 41 / Section 095
RCW 69.41.095: Opioid overdose reversal medication—Standing order permitted.
Status: in_force

(1)(a) A practitioner may prescribe, dispense, distribute, and deliver an opioid overdose reversal medication: (i) Directly to a person at risk of experiencing an opioid-related overdose; or (ii) by prescription, collaborative drug therapy agreement, standing order, or protocol to a first responder, family member, or other person or entity in a position to assist a person at risk of experiencing an opioid-related overdose. Any such prescription, standing order, or protocol is issued for a legitimate medical purpose in the usual course of professional practice. (b) At the time of prescribing, dispensing, distributing, or delivering the opioid overdose reversal medication, the practitioner shall inform the recipient that as soon as possible after administration of the opioid overdose reversal medication, the person at risk of experiencing an opioid-related overdose should be transported to a hospital or a first responder should be summoned. (2) A pharmacist may dispense an opioid overdose reversal medication pursuant to a prescription, collaborative drug therapy agreement, standing order, or protocol issued in accordance with subsection (1)(a) of this section and may administer an opioid overdose reversal medication to a person at risk of experiencing an opioid-related overdose. At the time of dispensing an opioid overdose reversal medication, a pharmacist shall provide written instructions on the proper response to an opioid-related overdose, including instructions for seeking immediate medical attention. The instructions to seek immediate medical attention must be conspicuously displayed. (3) Any person or entity may lawfully possess, store, deliver, distribute, or administer an opioid overdose reversal medication pursuant to a prescription, collaborative drug therapy agreement, standing order, or protocol issued by a practitioner in accordance with subsection (1) of this section. (4) The following individuals, if acting in good faith and with reasonable care, are not subject to criminal or civil liability or disciplinary action under chapter 18.130 RCW for any actions authorized by this section or the outcomes of any actions authorized by this section: (a) A practitioner who prescribes, dispenses, distributes, or delivers an opioid overdose reversal medication pursuant to subsection (1) of this section; (b) A pharmacist who dispenses an opioid overdose reversal medication pursuant to subsection (2) or (5)(a) of this section; (c) A person who possesses, stores, distributes, or administers an opioid overdose reversal medication pursuant to subsection (3) of this section. (5) The secretary or the secretary's designee may issue a standing order prescribing opioid overdose reversal medications to any person at risk of experiencing an opioid-related overdose or any person or entity in a position to assist a person at risk of experiencing an opioid-related overdose. The standing order may be limited to specific areas in the state or issued statewide. (a) A pharmacist shall dispense an opioid overdose reversal medication pursuant to a standing order issued in accordance with this subsection, consistent with the pharmacist's responsibilities to dispense prescribed legend drugs, and may administer an opioid overdose reversal medication to a person at risk of experiencing an opioid-related overdose. At the time of dispensing an opioid overdose reversal medication, a pharmacist shall provide written instructions on the proper response to an opioid-related overdose, including instructions for seeking immediate medical attention. The instructions to seek immediate medical attention must be conspicuously displayed. (b) Any person or entity may lawfully possess, store, deliver, distribute, or administer an opioid overdose reversal medication pursuant to a standing order issued in accordance with this subsection (5). The department, in coordination with the appropriate entity or entities, shall ensure availability of a training module that provides training regarding the identification of a person suffering from an opioid-related overdose and the use of opioid overdose reversal medications. The training must be available electronically and in a variety of media from the department. (c) This subsection (5) does not create a private cause of action. Notwithstanding any other provision of law, neither the state nor the secretary nor the secretary's designee has any civil liability for issuing standing orders or for any other actions taken pursuant to this chapter or for the outcomes of issuing standing orders or any other actions taken pursuant to this chapter. Neither the secretary nor the secretary's designee is subject to any criminal liability or professional disciplinary action for issuing standing orders or for any other actions taken pursuant to this chapter. (d) For purposes of this subsection (5), "standing order" means an order prescribing medication by the secretary or the secretary's designee. Such standing order can only be issued by a practitioner as defined in this chapter. (6) The labeling requirements of RCW 69.41.050 and 18.64.246 do not apply to opioid overdose reversal medications dispensed, distributed, or delivered pursuant to a prescription, collaborative drug therapy agreement, standing order, or protocol issued in accordance with this section. The individual or entity that dispenses, distributes, or delivers an opioid overdose reversal medication as authorized by this section shall ensure that directions for use are provided. (7) For purposes of this section, the following terms have the following meanings unless the context clearly requires otherwise: (a) "First responder" means: (i) A career or volunteer firefighter, law enforcement officer, paramedic as defined in RCW 18.71.200 , or first responder or emergency medical technician as defined in RCW 18.73.030 ; and (ii) an entity that employs or supervises an individual listed in (a)(i) of this subsection, including a volunteer fire department. (b) "Opioid overdose reversal medication" means any drug used to reverse an opioid overdose that binds to opioid receptors and blocks or inhibits the effects of opioids acting on those receptors. It does not include intentional administration via the intravenous route. (c) "Opioid-related overdose" means a condition including, but not limited to, decreased level of consciousness, nonresponsiveness, respiratory depression, coma, or death that: (i) Results from the consumption or use of an opioid or another substance with which an opioid was combined; or (ii) a lay person would reasonably believe to be an opioid-related overdose requiring medical assistance. (d) "Practitioner" means a health care practitioner who is authorized under RCW 69.41.030 to prescribe legend drugs. (e) "Standing order" or "protocol" means written or electronically recorded instructions, prepared by a prescriber, for distribution and administration of a drug by designated and trained staff or volunteers of an organization or entity, as well as other actions and interventions to be used upon the occurrence of clearly defined clinical events in order to improve patients' timely access to treatment.
RCW 69.50.407 — Washington Code / Title 69 / Chapter 50 / Section 407
RCW 69.50.407: Conspiracy.
Status: in_force

Any person who attempts or conspires to commit any offense defined in this chapter is punishable by imprisonment or fine or both which may not exceed the maximum punishment prescribed for the offense, the commission of which was the object of the attempt or conspiracy.
RCW 69.50.418 — Washington Code / Title 69 / Chapter 50 / Section 418
RCW 69.50.418: Tableting and encapsulating machines prohibited—Penalties.
Status: in_force

(1) It is unlawful for any person to possess, purchase, deliver, sell, or possess with intent to sell a tableting machine or encapsulating machine knowing, or under circumstances where one reasonably should know, that it will be used to manufacture, compound, convert, produce, process, prepare, or otherwise introduce into the human body a controlled substance, other than cannabis, in violation of this chapter. (2) Any person who violates this section is guilty of a class C felony. (3) For the purposes of this section: (a) "Encapsulating machine" means manual, semiautomatic, or fully automatic equipment that can be used to fill shells or capsules with powdered or granular solids or semisolid material to produce coherent solid contents. (b) "Tableting machine" means manual, semiautomatic, or fully automatic equipment that can be used to compact, compress, or mold powdered or granular solids or semisolid material to produce fused coherent solid tablets.
RCW 69.25.060 — Washington Code / Title 69 / Chapter 25 / Section 060
RCW 69.25.060: Egg handler's or dealer's license—Late renewal fee.
Status: in_force

If the application for the renewal of an egg handler's or dealer's license is not filed before the business license expiration date, the business license delinquency fee must be assessed under chapter 19.02 RCW and must be paid by the applicant before the renewal license is issued.
RCW 69.22.080 — Washington Code / Title 69 / Chapter 22 / Section 080
RCW 69.22.080: Application of administrative procedure act.
Status: in_force

The rights, remedies, and procedures respecting the administration of this chapter, including rule making, emergency actions, and permit suspension, revocation, or denial are governed by chapter 34.05 RCW.
RCW 69.50.401 — Washington Code / Title 69 / Chapter 50 / Section 401
RCW 69.50.401: Prohibited acts: A—Penalties.
Status: in_force

(1) Except as authorized by this chapter, it is unlawful for any person to manufacture, deliver, or possess with intent to manufacture or deliver, a controlled substance. (2) Any person who violates this section with respect to: (a) A controlled substance classified in Schedule I or II which is a narcotic drug or flunitrazepam, including its salts, isomers, and salts of isomers, classified in Schedule IV, is guilty of a class B felony and upon conviction may be imprisoned for not more than ten years, or (i) fined not more than twenty-five thousand dollars if the crime involved less than two kilograms of the drug, or both such imprisonment and fine; or (ii) if the crime involved two or more kilograms of the drug, then fined not more than one hundred thousand dollars for the first two kilograms and not more than fifty dollars for each gram in excess of two kilograms, or both such imprisonment and fine; (b) Amphetamine, including its salts, isomers, and salts of isomers, or methamphetamine, including its salts, isomers, and salts of isomers, is guilty of a class B felony and upon conviction may be imprisoned for not more than ten years, or (i) fined not more than twenty-five thousand dollars if the crime involved less than two kilograms of the drug, or both such imprisonment and fine; or (ii) if the crime involved two or more kilograms of the drug, then fined not more than one hundred thousand dollars for the first two kilograms and not more than fifty dollars for each gram in excess of two kilograms, or both such imprisonment and fine. Three thousand dollars of the fine may not be suspended. As collected, the first three thousand dollars of the fine must be deposited with the law enforcement agency having responsibility for cleanup of laboratories, sites, or substances used in the manufacture of the methamphetamine, including its salts, isomers, and salts of isomers. The fine moneys deposited with that law enforcement agency must be used for such clean-up cost; (c) Any other controlled substance classified in Schedule I, II, or III, is guilty of a class C felony punishable according to chapter 9A.20 RCW, except as provided in RCW 69.50.475 ; (d) A substance classified in Schedule IV, except flunitrazepam, including its salts, isomers, and salts of isomers, is guilty of a class C felony punishable according to chapter 9A.20 RCW; or (e) A substance classified in Schedule V, is guilty of a class C felony punishable according to chapter 9A.20 RCW. (3) The production, manufacture, processing, packaging, delivery, distribution, sale, or possession of cannabis in compliance with the terms set forth in RCW 69.50.360 , 69.50.363 , or 69.50.366 shall not constitute a violation of this section, this chapter, or any other provision of Washington state law. (4) The fines in this section apply to adult offenders only.
RCW 69.51A.130 — Washington Code / Title 69 / Chapter 51A / Section 130
RCW 69.51A.130: State and municipalities—Not subject to liability.
Status: in_force

(1) No civil or criminal liability may be imposed by any court on the state or its officers and employees for actions taken in good faith under this chapter and within the scope of their assigned duties. (2) No civil or criminal liability may be imposed by any court on cities, towns, and counties or other municipalities and their officers and employees for actions taken in good faith under this chapter and within the scope of their assigned duties.
RCW 69.91.010 — Washington Code / Title 69 / Chapter 91 / Section 010
RCW 69.91.010: Definitions.
Status: in_force

The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1) "Food product" includes any article other than drugs, whether in raw or prepared form, liquid or solid, or packaged or unpackaged, and that is used for human consumption. (2) "Halal" means a food product prepared, processed, and maintained in strict accordance with the requisites of Islamic principles and customs including, but not limited to, the slaughter of an animal and preparation thereof for human consumption. (3) "Person" includes individuals, partnerships, corporations, and associations.
RCW 69.50.303 — Washington Code / Title 69 / Chapter 50 / Section 303
RCW 69.50.303: Registration.
Status: in_force

(1) The commission shall register an applicant to manufacture, distribute, dispense, or conduct research with controlled substances included in RCW 69.50.204 , 69.50.206 , 69.50.208 , 69.50.210 , and 69.50.212 unless the commission determines that the issuance of that registration would be inconsistent with the public interest. In determining the public interest, the commission shall consider the following factors: (a) maintenance of effective controls against diversion of controlled substances into other than legitimate medical, scientific, research, or industrial channels; (b) compliance with applicable state and local law; (c) promotion of technical advances in the art of manufacturing controlled substances and the development of new substances; (d) any convictions of the applicant under any laws of another country or federal or state laws relating to any controlled substance; (e) past experience in the manufacture or distribution of controlled substances, and the existence in the applicant's establishment of effective controls against diversion of controlled substances into other than legitimate medical, scientific, research, or industrial channels; (f) furnishing by the applicant of false or fraudulent material in any application filed under this chapter; (g) suspension or revocation of the applicant's federal registration to manufacture, distribute, or dispense controlled substances as authorized by federal law; and (h) any other factors relevant to and consistent with the public health and safety. (2) Registration under subsection (1) of this section does not entitle a registrant to manufacture or distribute controlled substances included in Schedule I or II other than those specified in the registration. (3) Practitioners must be registered, or exempted under RCW 69.50.302 (4), to dispense any controlled substances or to conduct research with controlled substances included in Schedules II through V if they are authorized to dispense or conduct research under the law of this state. The commission need not require separate registration under this Article for practitioners engaging in research with nonnarcotic substances included in Schedules II through V where the registrant is already registered under this Article in another capacity. Practitioners registered under federal law to conduct research with substances included in Schedule I may conduct research with substances included in Schedule I within this state upon furnishing the commission evidence of that federal registration. (4) A manufacturer or distributor registered under the federal Controlled Substances Act, 21 U.S.C. Sec. 801 et seq., may submit a copy of the federal application as an application for registration as a manufacturer or distributor under this section. The commission may require a manufacturer or distributor to submit information in addition to the application for registration under the federal act.
RCW 69.43.160 — Washington Code / Title 69 / Chapter 43 / Section 160
RCW 69.43.160: Ephedrine, pseudoephedrine, phenylpropanolamine—Methods to prevent sales violations—Department of health preparation of sign summarizing prohibitions.
Status: in_force

(1) To prevent violations of RCW 69.43.110 , every licensee and registrant under chapter 18.64 RCW, who sells at retail any products containing ephedrine, pseudoephedrine, or phenylpropanolamine, or their salts, isomers, or salts of isomers, shall do either or may do both of the following: (a) Program scanners, cash registers, or other electronic devices used to record sales in a manner that will alert persons handling transactions to potential violations of RCW 69.43.110 (1) and/or prevent such violations; or (b) Place one or more signs on the premises to notify customers of the prohibitions of RCW 69.43.110 . Any such sign may, but is not required to, conform to the language and format prepared by the department of health under subsection (2) of this section. (2) The department of health shall prepare language and format for a sign summarizing the prohibitions in RCW 69.43.110 and 69.43.120 and make the language and format available to licensees and registrants under chapter 18.64 RCW, for voluntary use in their places of business to inform customers and employees of the prohibitions. Nothing in this section requires the department of health to provide licensees or registrants with copies of signs, or any licensee or registrant to use the specific language or format prepared by the department under this subsection.
RCW 69.30.085 — Washington Code / Title 69 / Chapter 30 / Section 085
RCW 69.30.085: License, certificate of approval—Denial, revocation, suspension—Prohibited acts—Penalties.
Status: in_force

(1) A person, or its director or officer, whose license or certificate of approval is denied, revoked, or suspended as a result of violations of this chapter or rules adopted under this chapter may not: (a) Supervise, be employed by, or manage a shellfish operation licensed or certified under this chapter or rules adopted under this chapter; (b) Participate in the harvesting, shucking, packing, or shipping of shellfish in commercial quantities or for sale; (c) Participate in the brokering of shellfish, purchase of shellfish for resale, or retail sale of shellfish; or (d) Engage in any activity associated with selling or offering to sell shellfish. (2) Subsections (1)(c) and (d) of this section do not apply to retail purchases of shellfish for personal use. (3) Subsection (1) of this section applies to a person only during the period of time in which that person's license or certificate of approval is denied, revoked, or suspended. (4) Unlawful operations under subsection (1) of this section when a license or certificate of approval is denied, revoked, or suspended is a class C felony. Upon conviction, the department shall order that the person's license or certificate of approval be revoked for a period of at least five years, or that a person whose application for a license or certificate of approval was denied be ineligible to reapply for a period of at least five years. (5) A license or certificate of approval issued under this chapter may not be assigned or transferred in any manner without department approval.
RCW 69.90.020 — Washington Code / Title 69 / Chapter 90 / Section 020
RCW 69.90.020: Sale of "kosher" and "kosher style" food products prohibited if not kosher—Representations—Penalty.
Status: in_force

(1) No person may knowingly sell or offer for sale any food product represented as "kosher" or "kosher style" when that person knows that the food product is not kosher and when the representation is likely to cause a prospective purchaser to believe that it is kosher. Such a representation can be made orally or in writing, or by display of a sign, mark, insignia, or simulation. (2) A person violating this section is guilty of a gross misdemeanor.
RCW 69.77.090 — Washington Code / Title 69 / Chapter 77 / Section 090
RCW 69.77.090: Pharmacy quality assurance commission may adopt rules.
Status: in_force

The pharmacy quality assurance commission may adopt rules necessary to implement this chapter.
RCW 69.06.080 — Washington Code / Title 69 / Chapter 06 / Section 080
RCW 69.06.080: Chapter not applicable to persons who meet requirements of RCW 70.128.250.
Status: in_force

Except for the food safety training standards adopted by the state board of health under RCW 69.06.010 , the provisions of this chapter do not apply to persons who work in adult family homes and successfully complete training and continuing education as required by RCW 70.128.250 .
RCW 69.70.070 — Washington Code / Title 69 / Chapter 70 / Section 070
RCW 69.70.070: Liability.
Status: in_force

(1) A drug manufacturer acting in good faith may not, in the absence of a finding of gross negligence, be subject to criminal prosecution or liability in tort or other civil action, for injury, death, or loss to person or property for matters relating to the donation, acceptance, or dispensing of any drug manufactured by the drug manufacturer that is donated by any person under the program including, but not limited to: (a) Liability for failure to transfer or communicate product or consumer information or the expiration date of the donated prescription drug; and (b) Liability related to prescription drugs that can only be dispensed to a patient registered with the manufacturer of that drug, in accordance with the requirements established by the federal food and drug administration. (2) Any person or entity, other than a drug manufacturer subject to subsection (1) of this section, acting in good faith in donating, accepting, or distributing prescription drugs under this chapter is immune from criminal prosecution, professional discipline, or civil liability of any kind for any injury, death, or loss to any person or property relating to such activities other than acts or omissions constituting gross negligence or willful or wanton misconduct. (3) The immunity provided under subsection (1) of this section does not absolve a drug manufacturer of a criminal or civil liability that would have existed but for the donation, nor does such donation increase the liability of the drug manufacturer in such an action.
RCW 69.28.100 — Washington Code / Title 69 / Chapter 28 / Section 100
RCW 69.28.100: Marks for "slack-filled" container.
Status: in_force

Any slack-filled container shall be conspicuously marked "slack-filled".
RCW 69.10.005 — Washington Code / Title 69 / Chapter 10 / Section 005
RCW 69.10.005: Definitions.
Status: in_force

For the purpose of this chapter: (1) "Food storage warehouse" means any premises, establishment, building, room area, facility, or place, in whole or in part, where food is stored, kept, or held for wholesale distribution to other wholesalers or to retail outlets, restaurants, and any such other facility selling or distributing to the ultimate consumer. Food storage warehouses include, but are not limited to, facilities where food is kept or held refrigerated or frozen and include facilities where food is stored to the account of another firm and/or is owned by the food storage warehouse. "Food storage warehouse" does not include grain elevators or fruit and vegetable storage and packing houses that store, pack, and ship fresh fruit and vegetables even though they may use refrigerated or controlled atmosphere storage practices in their operation. However, this chapter applies to multiple food storage operations that also distribute or ripen fruits and vegetables. (2) "Department" means the Washington department of agriculture. (3) "Director" means the director of the Washington department of agriculture. (4) "Food" means the same as defined in the food safety and security act under chapter 15.130 RCW. (5) "Independent sanitation consultant" means an individual, partnership, cooperative, or corporation that by reason of education, certification, and experience has satisfactorily demonstrated expertise in food and dairy sanitation and is approved by the director to advise on such areas including, but not limited to: Principles of cleaning and sanitizing food processing plants and equipment; rodent, insect, bird, and other pest control; principles of hazard analysis critical control point; basic food product labeling; principles of proper food storage and protection; proper personnel work practices and attire; sanitary design, construction, and installation of food plant facilities, equipment, and utensils; and other pertinent food safety issues.
RCW 69.75.040 — Washington Code / Title 69 / Chapter 75 / Section 040
RCW 69.75.040: Construction of chapter.
Status: in_force

(1) Nothing in this chapter is construed to impose any compliance requirement on a retail entity other than manually obtaining and verifying proof of age as a condition of sale, including placement of products in a specific place within a store, other restrictions on consumers' direct access to finished drug products, or the maintenance of transaction records. (2) The provisions of this chapter do not apply to medication containing dextromethorphan that is sold pursuant to a valid prescription.
RCW 69.50.508 — Washington Code / Title 69 / Chapter 50 / Section 508
RCW 69.50.508: Education and research.
Status: in_force

(a) [(1)] The commission may carry out educational programs designed to prevent and deter misuse and abuse of controlled substances. In connection with these programs it may: (1) [(a)] promote better recognition of the problems of misuse and abuse of controlled substances within the regulated industry and among interested groups and organizations; (2) [(b)] assist the regulated industry and interested groups and organizations in contributing to the reduction of misuse and abuse of controlled substances; (3) [(c)] consult with interested groups and organizations to aid them in solving administrative and organizational problems; (4) [(d)] evaluate procedures, projects, techniques, and controls conducted or proposed as part of educational programs on misuse and abuse of controlled substances; (5) [(e)] disseminate the results of research on misuse and abuse of controlled substances to promote a better public understanding of what problems exist and what can be done to combat them; and (6) [(f)] assist in the education and training of state and local law enforcement officials in their efforts to control misuse and abuse of controlled substances. (b) [(2)] The commission may encourage research on misuse and abuse of controlled substances. In connection with the research, and in furtherance of the enforcement of this chapter, it may: (1) [(a)] establish methods to assess accurately the effects of controlled substances and identify and characterize those with potential for abuse; (2) [(b)] make studies and undertake programs of research to: (i) develop new or improved approaches, techniques, systems, equipment and devices to strengthen the enforcement of this chapter; (ii) determine patterns of misuse and abuse of controlled substances and the social effects thereof; and, (iii) improve methods for preventing, predicting, understanding and dealing with the misuse and abuse of controlled substances; and, (3) [(c)] enter into contracts with public agencies, institutions of higher education, and private organizations or individuals for the purpose of conducting research, demonstrations, or special projects which bear directly on misuse and abuse of controlled substances. (c) [(3)] The commission may enter into contracts for educational and research activities without performance bonds. (d) [(4)] The commission may authorize persons engaged in research on the use and effects of controlled substances to withhold the names and other identifying characteristics of individuals who are the subjects of the research. Persons who obtain this authorization are not compelled in any civil, criminal, administrative, legislative, or other proceeding to identify the individuals who are the subjects of research for which the authorization was obtained. (e) [(5)] The commission may authorize the possession and distribution of controlled substances by persons engaged in research. Persons who obtain this authorization are exempt from state prosecution for possession and distribution of controlled substances to the extent of the authorization.
RCW 69.38.050 — Washington Code / Title 69 / Chapter 38 / Section 050
RCW 69.38.050: False representation—Penalty.
Status: in_force

Any person making any false representation to a seller when purchasing a poison is guilty of a gross misdemeanor.
RCW 69.50.506 — Washington Code / Title 69 / Chapter 50 / Section 506
RCW 69.50.506: Burden of proof; liabilities.
Status: in_force

(a) [(1)] It is not necessary for the state to negate any exemption or exception in this chapter in any complaint, information, indictment, or other pleading or in any trial, hearing, or other proceeding under this chapter. The burden of proof of any exemption or exception is upon the person claiming it. (b) [(2)] In the absence of proof that a person is the duly authorized holder of an appropriate registration or order form issued under this chapter, he or she is presumed not to be the holder of the registration or form. The burden of proof is upon him or her to rebut the presumption. (c) [(3)] No liability is imposed by this chapter upon any authorized state, county, or municipal officer, engaged in the lawful performance of his or her duties.
RCW 69.04.130 — Washington Code / Title 69 / Chapter 04 / Section 130
RCW 69.04.130: Petitions may be consolidated.
Status: in_force

Two or more petitions under RCW 69.04.120 , which pend at the same time and which present the same issue and claimant hereunder, shall be consolidated for simultaneous determination by one court of jurisdiction, upon application to any court of jurisdiction by the director or by such claimant.
RCW 69.04.019 — Washington Code / Title 69 / Chapter 04 / Section 019
RCW 69.04.019: "Advertisement."
Status: in_force

The term "advertisement" means all representations, other than by labeling, for the purpose of inducing, or which are likely to induce, directly or indirectly, the purchase of food, drugs, devices, or cosmetics.
RCW 69.75.050 — Washington Code / Title 69 / Chapter 75 / Section 050
RCW 69.75.050: Preemption.
Status: in_force

This chapter preempts any ordinance regulating the sale, distribution, receipt, or possession of dextromethorphan enacted by a county, city, town, or other political subdivision of this state, and dextromethorphan is not subject to further regulation by such subdivisions.
RCW 69.53.030 — Washington Code / Title 69 / Chapter 53 / Section 030
RCW 69.53.030: Unlawful use of fortified building—Penalty.
Status: in_force

(1) It is unlawful for any person to use a building, room, space, or enclosure specifically designed to suppress law enforcement entry in order to unlawfully manufacture, deliver, sell, store, or give away any controlled substance under chapter 69.50 RCW, legend drug under chapter 69.41 RCW, or imitation controlled substance under chapter 69.52 RCW. (2) A violation of this section is a class C felony punishable under chapter 9A.20 RCW.
RCW 69.28.070 — Washington Code / Title 69 / Chapter 28 / Section 070
RCW 69.28.070: "Marked" defined—When honey need not be marked.
Status: in_force

The term "marked" shall mean printed in the English language on the top, front or side of any container containing honey: PROVIDED, That it shall not be necessary to mark honey sold by the producer thereof to any distributor, packer or manufacturer with the net weight, color or grade if the honey is to be used in the manufacture of honey products or is to be graded and packaged by the distributor or packer for resale.
RCW 69.04.014 — Washington Code / Title 69 / Chapter 04 / Section 014
RCW 69.04.014: "Immediate container."
Status: in_force

The term "immediate container" does not include package liners.
RCW 69.51A.270 — Washington Code / Title 69 / Chapter 51A / Section 270
RCW 69.51A.270: Extracting or separating cannabis resin, producing or processing any form of cannabis concentrates or cannabis-infused products—State liquor and cannabis board to adopt rules.
Status: in_force

(1) Once the state liquor and cannabis board adopts rules under subsection (2) of this section, qualifying patients or designated providers may only extract or separate the resin from cannabis or produce or process any form of cannabis concentrates or cannabis-infused products in accordance with those standards. (2) The state liquor and cannabis board must adopt rules permitting qualifying patients and designated providers to extract or separate the resin from cannabis using noncombustable methods. The rules must provide the noncombustible methods permitted and any restrictions on this practice.
RCW 69.25.107 — Washington Code / Title 69 / Chapter 25 / Section 107
RCW 69.25.107: Commercial egg layer operations—Requirements.
Status: in_force

(1) All commercial egg layer operations required under RCW 69.25.065 to meet the American humane association facility system plan, or an equivalent to the plan, must also ensure that all hens in the operation are provided with: (a) No less than one hundred sixteen and three-tenths square inches of space per hen; and (b) Access to areas for nesting, scratching, and perching. (2) All commercial egg layer operations required under RCW 69.25.065 to house egg-laying hens with at a minimum the amount of usable floor space per hen required by the 2017 edition of the united egg producers' Animal Husbandry Guidelines for United States Egg-Laying Flocks: Guidelines for Cage-Free Housing, or a subsequent version of the plan recognized by the department in rule as providing equal or more useable floor space per egg-laying hen, must ensure that the hens are housed in a cage-free housing system. (3) Subsection (2) of this section does not apply: (a) During medical research; (b) During examination, testing, individual treatment, or operation for veterinary purposes; (c) During transportation, or depopulation operations for periods of no more than seven days in any eighteen-month period; (d) During rodeo exhibitions, state or county fair exhibitions, 4-H programs, and similar exhibitions; (e) During the slaughter of an egg-laying hen in accordance with applicable laws and regulations; or (f) During temporary periods for animal husbandry purposes of no more than six hours in any twenty-four hour period, and no more than twenty-four hours in any thirty-day period. (4) The requirements of this section apply for any commercial egg layer operation on the same dates that RCW 69.25.065 requires compliance with the American humane association facility system plan or an equivalent to the plan, or requires housing egg-laying hens with at a minimum the amount of usable floor space per hen required by the united egg producers' Animal Husbandry Guidelines for United States Egg-Laying Flocks: Guidelines for Cage-Free Housing or an equivalent to the guidelines.
RCW 69.57.070 — Washington Code / Title 69 / Chapter 57 / Section 070
RCW 69.57.070: Violations.
Status: in_force

(1) A covered entity that violates chapter 13, Laws of 2025 is subject to a civil penalty of $10,000 for the first violation, and a civil penalty of no more than $1,000,000 for a second or subsequent violation. (2)(a) The attorney general, prosecuting attorney within the relevant jurisdiction, or any aggrieved individual may bring an action to impose a civil penalty for a violation of chapter 13, Laws of 2025. A civil penalty imposed pursuant to this section does not exclude any other public or private cause of action, whether criminal or civil. (b) Any aggrieved individual, other than the attorney general, who prevails in a civil action against a covered entity under chapter 13, Laws of 2025 is entitled to reasonable attorney fees, costs, and the greater of actual economic damages or $3,000.
RCW 69.28.440 — Washington Code / Title 69 / Chapter 28 / Section 440
RCW 69.28.440: Sample of honey or product may be obtained—Procedure.
Status: in_force

The claimant in any proceeding by petition under this chapter, as now or hereafter amended, shall be entitled to receive a representative sample of the honey or product subject to such proceeding, upon application to the court of jurisdiction made at any time after such petition and prior to the hearing thereon.
RCW 69.04.740 — Washington Code / Title 69 / Chapter 04 / Section 740
RCW 69.04.740: Regulations to conform with federal regulations.
Status: in_force

The purpose of this chapter being to promote uniformity of state legislation with the federal act, the director is hereby authorized (1) to adopt, insofar as applicable, the regulations from time to time promulgated under the federal act; and (2) to make the regulations promulgated under this chapter conform, insofar as practicable, with those promulgated under the federal act.
RCW 69.51.010 — Washington Code / Title 69 / Chapter 51 / Section 010
RCW 69.51.010: Short title.
Status: in_force

This chapter may be cited as the Controlled Substances Therapeutic Research Act.
RCW 69.28.260 — Washington Code / Title 69 / Chapter 28 / Section 260
RCW 69.28.260: "Person" defined.
Status: in_force

The term "person" includes individual, partnership, corporation and/or association.
RCW 69.41.085 — Washington Code / Title 69 / Chapter 41 / Section 085
RCW 69.41.085: Medication assistance—Community-based care setting.
Status: in_force

Individuals residing in community-based care settings, such as adult family homes, assisted living facilities, and residential care settings for individuals with developmental disabilities, including an individual's home, may receive medication assistance. Nothing in this chapter affects the right of an individual to refuse medication or requirements relating to informed consent.
RCW 69.51A.060 — Washington Code / Title 69 / Chapter 51A / Section 060
RCW 69.51A.060: Crimes—Limitations of chapter.
Status: in_force

(1) It shall be a class 3 civil infraction to use or display medical cannabis in a manner or place which is open to the view of the general public. (2) Nothing in this chapter establishes a right of care as a covered benefit or requires any state purchased health care as defined in RCW 41.05.011 or other health carrier or health plan as defined in Title 48 RCW to be liable for any claim for reimbursement for the medical use of cannabis. Such entities may enact coverage or noncoverage criteria or related policies for payment or nonpayment of medical cannabis in their sole discretion. (3) Nothing in this chapter requires any health care professional to authorize the medical use of cannabis for a patient. (4) Nothing in this chapter requires any accommodation of any on-site medical use of cannabis in any place of employment, in any youth center, in any correctional facility, or smoking cannabis in any public place or hotel or motel. (5) Nothing in this chapter authorizes the possession or use of cannabis, cannabis concentrates, useable cannabis, or cannabis-infused products on federal property. (6) Nothing in this chapter authorizes the use of medical cannabis by any person who is subject to the Washington code of military justice in chapter 38.38 RCW. (7) Employers may establish drug-free work policies. Nothing in this chapter requires an accommodation for the medical use of cannabis if an employer has a drug-free workplace. (8) No person shall be entitled to claim the protection from arrest and prosecution under RCW 69.51A.040 for engaging in the medical use of cannabis in a way that endangers the health or well-being of any person through the use of a motorized vehicle on a street, road, or highway, including violations of RCW 46.61.502 or 46.61.504 , or equivalent local ordinances.
RCW 69.50.348 — Washington Code / Title 69 / Chapter 50 / Section 348
RCW 69.50.348: Representative samples of cannabis, useable cannabis, or cannabis-infused products—Product testing—Fees.
Status: in_force

(1) On a schedule determined by the board, every licensed cannabis producer and processor must submit representative samples of cannabis, useable cannabis, or cannabis-infused products produced or processed by the licensee to an independent, third-party testing laboratory meeting the accreditation requirements established by the state department of agriculture. The purpose of testing representative samples is to certify compliance with quality assurance and product standards adopted by the board under RCW 69.50.342 or the department of health under RCW 69.50.375 . In conducting tests of cannabis product samples, testing laboratories must adhere to laboratory quality standards adopted by the state department of agriculture under chapter 15.150 RCW. Any sample remaining after testing shall be destroyed by the laboratory or returned to the licensee submitting the sample. (2) Independent, third-party testing laboratories performing cannabis product testing under subsection (1) of this section must obtain and maintain accreditation. (3) Licensees must submit the results of inspection and testing for quality assurance and product standards required under RCW 69.50.342 to the board on a form developed by the board. (4) If a representative sample inspected and tested under this section does not meet the applicable quality assurance and product standards established by the board then, except as otherwise provided by the board in rule, the entire lot from which the sample was taken must be destroyed. (5) The department of agriculture may determine, assess, and collect annual fees to support the direct and indirect costs of implementing a state cannabis product testing laboratory accreditation program and laboratory quality standards program, except for the initial program development costs. The department of agriculture may establish a payment schedule requiring periodic installments of the annual fee. The department of agriculture must review and update its fee schedule biennially. The costs of cannabis product testing laboratory accreditation are those incurred by the department of agriculture in administering and enforcing the accreditation program. The costs may include, but are not limited to, the costs incurred in undertaking the following accreditation functions: (a) Evaluating the protocols and procedures used by a laboratory; (b) Performing on-site audits; (c) Evaluating participation and successful completion of proficiency testing; (d) Determining the capability of a laboratory to produce accurate and reliable test results; and (e) Such other accreditation activities as the department of agriculture deems appropriate. (6) The department of agriculture and the interagency coordination team created in RCW 15.150.020 must act cooperatively to ensure effective implementation and administration of this section. (7) All fees collected under this section must be deposited in the dedicated cannabis account created in RCW 69.50.530 .
RCW 69.41.072 — Washington Code / Title 69 / Chapter 41 / Section 072
RCW 69.41.072: Violations of chapter 69.50 RCW not to be charged under chapter 69.41 RCW—Exception.
Status: in_force

Any offense which is a violation of chapter 69.50 RCW other than RCW 69.50.4012 shall not be charged under this chapter.
RCW 69.50.404 — Washington Code / Title 69 / Chapter 50 / Section 404
RCW 69.50.404: Penalties under other laws.
Status: in_force

Any penalty imposed for violation of this chapter is in addition to, and not in lieu of, any civil or administrative penalty or sanction otherwise authorized by law.
RCW 69.50.450 — Washington Code / Title 69 / Chapter 50 / Section 450
RCW 69.50.450: Butane or other explosive gases.
Status: in_force

(1) Nothing in this chapter permits anyone other than a validly licensed cannabis processor to use butane or other explosive gases to extract or separate resin from cannabis or to produce or process any form of cannabis concentrates or cannabis-infused products that include cannabis concentrates not purchased from a validly licensed cannabis retailer as an ingredient. The extraction or separation of resin from cannabis, the processing of cannabis concentrates, and the processing of cannabis-infused products that include cannabis concentrates not purchased from a validly licensed cannabis retailer as an ingredient by any person other than a validly licensed cannabis processor each constitute manufacture of cannabis in violation of RCW 69.50.401 . Cooking oil, butter, and other nonexplosive home cooking substances may be used to make cannabis extracts for noncommercial personal use. (2) Except for the use of butane, the board may not enforce this section until it has adopted the rules required by RCW 69.51A.270 .
RCW 69.43.030 — Washington Code / Title 69 / Chapter 43 / Section 030
RCW 69.43.030: Exemptions.
Status: in_force

RCW 69.43.010 and 69.43.020 do not apply to any of the following: (1) Any pharmacist or other authorized person who sells or furnishes a substance upon the prescription of a practitioner, as defined in chapter 69.41 RCW; (2) Any practitioner who administers or furnishes a substance to his or her patients; (3) Any manufacturer or wholesaler licensed by the pharmacy quality assurance commission who sells, transfers, or otherwise furnishes a substance to a licensed pharmacy or practitioner; (4) Any sale, transfer, furnishing, or receipt of any drug that contains ephedrine, phenylpropanolamine, or pseudoephedrine, or of any cosmetic that contains a substance specified in RCW 69.43.010 (1), if such drug or cosmetic is lawfully sold, transferred, or furnished, over the counter without a prescription under chapter 69.04 or 69.41 RCW.
RCW 69.70.080 — Washington Code / Title 69 / Chapter 70 / Section 080
RCW 69.70.080: Availability of access.
Status: in_force

Access to prescription drugs and supplies under this chapter is subject to availability. Nothing in this chapter establishes an entitlement to receive prescription drugs and supplies through the program.
RCW 69.07.085 — Washington Code / Title 69 / Chapter 07 / Section 085
RCW 69.07.085: Sanitary certificates—Fee.
Status: in_force

The department may issue sanitary certificates to food processors under this chapter subject to such requirements as it may establish by rule. The fee for issuance shall be seventy-five dollars per certificate. Fees collected under this section shall be deposited in the agricultural local fund.
RCW 69.07.080 — Washington Code / Title 69 / Chapter 07 / Section 080
RCW 69.07.080: Inspections by department—Access—When.
Status: in_force

For purpose of determining whether the rules adopted pursuant to RCW 69.07.020 , as now or hereafter amended are complied with, the department shall have access for inspection purposes to any part, portion or area of a food processing plant, and any records required to be kept under the provisions of this chapter or rules and regulations adopted hereunder. Such inspection shall, when possible, be made during regular business hours or during any working shift of said food processing plant. The department may, however, inspect such food processing plant at any time when it has received information that an emergency affecting the public health has arisen and such food processing plant is or may be involved in the matters causing such emergency.
RCW 69.04.500 — Washington Code / Title 69 / Chapter 04 / Section 500
RCW 69.04.500: Drugs—Misbranding by failure to give directions for use and warnings.
Status: in_force

A drug or device shall be deemed to be misbranded unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users: PROVIDED, That where any requirement of clause (1) of this section as applied to any drug or device, is not necessary for the protection of the public health, the director shall promulgate regulations exempting such drug or device from such requirements. Such regulations shall include the exemptions prescribed under section 502(f)(1) of the federal act, insofar as such exemptions are applicable hereunder.
RCW 15.30.050 — Washington Code / Title 69 / Chapter 30 / Section 050
RCW 15.30.050: Enforcement—Rules authorized, procedure.
Status: in_force

The director shall enforce and carry out the provisions of this chapter and may adopt the necessary rules to carry out its purposes. The adoption of rules shall be subject to the provisions of chapter 34.05 RCW, concerning the adoption of rules, as enacted or hereafter amended.(1) It is unlawful for a person to harvest shellfish from shellfish growing areas in a commercial quantity or for sale for human consumption unless the shellfish growing area: (a) Has a valid certificate of approval; and (b) Meets the requirements of this chapter and the rules adopted under this chapter. (2) A person may not remove shellfish in a commercial quantity or for sale for human consumption from a shellfish growing area in the state of Washington unless: (a) The person has received a certificate of approval for the shellfish growing area from the department; and (b) Approved shellfish tags are affixed to each container of shellstock prior to removal from the shellfish growing area, except bulk tagging is permitted as allowed in the national shellfish sanitation program model ordinance. (3) Before issuing a certificate of approval, the department shall inspect the shellfish growing area. The department shall issue a certificate of approval if the area meets the requirements of this chapter and the rules adopted under this chapter. (4) A certificate of approval is valid for a period of twelve months. The department may revoke a certificate of approval at any time the area is found out of compliance with the requirements of this chapter or the rules adopted under this chapter. (5) It is unlawful to remove shellfish from shellfish growing areas without a certificate of approval in a commercial quantity for purposes other than human consumption, including but not limited to use as bait or seed, unless: (a) The shellfish operation and shellfish growing area is readily available to monitoring and inspections; and (b) The department has determined the shellfish operation is designed to ensure that shellfish harvested from such an area is not diverted for human consumption. (6) Nothing in this section prohibits a person from removing shellfish for use as bait or seed from an approved shellfish growing area. (7) The department's certificate of approval to harvest shellfish for purposes other than human consumption shall specify: (a) The date or dates and time of harvest; (b) All applicable conditions of harvest; (c) Identification by tagging, dying, or other department-approved means; and (d) Information about the removal method, transportation method, processing technique, sale details, and other factors to ensure that shellfish harvested from such areas are not diverted for human consumption.
RCW 69.45.080 — Washington Code / Title 69 / Chapter 45 / Section 080
RCW 69.45.080: Violations of chapter—Manufacturer's liability—Enforcement—Seizure of drug samples.
Status: in_force

(1) The manufacturer is responsible for the actions and conduct of its representatives with regard to drug samples. (2) Chapter 18.64 RCW governs the denial of licenses and the discipline of persons registered under this chapter. (3) Specific drug samples which are distributed in this state in violation of this chapter, following notification by the commission, shall be subject to seizure following the procedures set out in RCW 69.41.060 .
RCW 69.28.270 — Washington Code / Title 69 / Chapter 28 / Section 270
RCW 69.28.270: "Slack-filled" defined.
Status: in_force

The term "slack-filled" shall mean that the contents of any container occupy less than ninety-five percent of the volume of the closed container.
RCW 69.75.020 — Washington Code / Title 69 / Chapter 75 / Section 020
RCW 69.75.020: Retail sales—Proof of age from purchaser—Unlawful acts, exceptions—Penalties.
Status: in_force

(1) A person making a retail sale of a finished drug product containing any quantity of dextromethorphan must require and obtain proof of age from the purchaser before completing the sale, unless from the purchaser's outward appearance the person making the sale would reasonably presume the purchaser to be twenty-five years of age or older. (2) It is unlawful for any: (a) Commercial entity to knowingly or willfully sell or trade a finished drug product containing any quantity of dextromethorphan to a person less than eighteen years of age; or (b) Person who is less than eighteen years of age to purchase a finished drug product containing any quantity of dextromethorphan. (3) Subsection (2)(a) and (b) of this section do [does] not apply if an individual under eighteen years of age: (a) Supplies proof at the time of sale that such individual is actively enrolled in the military and presents a valid military identification card; or (b) Supplies proof of emancipation. (4)(a) Any manufacturer, distributor, or retailer whose employee or representative, during the course of the employee's or representative's employment or association with that manufacturer, distributor, or retailer sells or trades dextromethorphan in violation of subsection (2)(a) of this section must be given a written warning by a law enforcement agency for the first offense. For any subsequent offense, the manufacturer, distributor, or retailer is guilty of a class 1 civil infraction as provided in RCW 7.80.120 , except for any manufacturer, distributor, or retailer who demonstrates a good faith effort to comply with the requirements of this chapter. (b) Any employee or representative of a manufacturer, distributor, or retailer who, during the course of the employee's or representative's employment or association with that manufacturer, distributor, or retailer sells or trades dextromethorphan in violation of subsection (2)(a) of this section must be given a written warning by a law enforcement agency for the first offense. For any subsequent offense, the employee or representative is guilty of a class 1 civil infraction as provided in RCW 7.80.120 . (c) Any person who purchases dextromethorphan in violation of subsection (2)(b) of this section must be given a written warning by a law enforcement agency for the first offense. For any subsequent offense, the person is guilty of a class 1 civil infraction as provided in RCW 7.80.120 .
RCW 69.57.040 — Washington Code / Title 69 / Chapter 57 / Section 040
RCW 69.57.040: Sale or transfer of covered products to commercial businesses.
Status: in_force

(1) A covered entity may sell or transfer a covered product to a verified commercial business if, prior to the sale or transfer of the covered product: (a) The commercial business affirms that the commercial business requires covered products, which must include the commercial business providing its employer identification number to the covered entity; and (b) The covered entity has a system that verifies that the commercial business requires a covered product, including verifying the employer identification number. (2) The following systems, whether relied on solely or in combination, do not satisfy the verification obligation of the covered entity specified in subsection (1) of this section: (a) A sale verification system relying on the commercial business simply providing a statement of commercial need and intended usage without additional verification; (b) A sale verification system relying on the commercial business using tick boxes to confirm they are a commercial business and require covered products; or (c) A sale verification system relying on the commercial business using an "accept" statement for the commercial business to confirm that they have read the terms and conditions.
RCW 69.50.550 — Washington Code / Title 69 / Chapter 50 / Section 550
RCW 69.50.550: Cost-benefit evaluations.
Status: in_force

(1) The Washington state institute for public policy shall conduct cost-benefit evaluations of the implementation of chapter 3, Laws of 2013. A preliminary report, and recommendations to appropriate committees of the legislature, shall be made by September 1, 2015, and the first final report with recommendations by September 1, 2017. Subsequent reports shall be due September 1, 2022, and September 1, 2032. (2) The evaluation of the implementation of chapter 3, Laws of 2013 shall include, but not necessarily be limited to, consideration of the following factors: (a) Public health, to include but not be limited to: (i) Health costs associated with cannabis use; (ii) Health costs associated with criminal prohibition of cannabis, including lack of product safety or quality control regulations and the relegation of cannabis to the same illegal market as potentially more dangerous substances; and (iii) The impact of increased investment in the research, evaluation, education, prevention and intervention programs, practices, and campaigns identified in RCW 69.50.363 on rates of cannabis-related maladaptive substance use and diagnosis of cannabis-related substance use disorder, substance abuse, or substance dependence, as these terms are defined in the Diagnostic and Statistical Manual of Mental Disorders; (b) Public safety, to include but not be limited to: (i) Public safety issues relating to cannabis use; and (ii) Public safety issues relating to criminal prohibition of cannabis; (c) Youth and adult rates of the following: (i) Cannabis use; (ii) Maladaptive use of cannabis; and (iii) Diagnosis of cannabis-related substance use disorder, substance abuse, or substance dependence, including primary, secondary, and tertiary choices of substance; (d) Economic impacts in the private and public sectors, including but not limited to: (i) Jobs creation; (ii) Workplace safety; (iii) Revenues; and (iv) Taxes generated for state and local budgets; (e) Criminal justice impacts, to include but not be limited to: (i) Use of public resources like law enforcement officers and equipment, prosecuting attorneys and public defenders, judges and court staff, the Washington state patrol crime lab and identification and criminal history section, jails and prisons, and misdemeanant and felon supervision officers to enforce state criminal laws regarding cannabis; and (ii) Short and long-term consequences of involvement in the criminal justice system for persons accused of crimes relating to cannabis, their families, and their communities; and (f) State and local agency administrative costs and revenues.
RCW 69.28.360 — Washington Code / Title 69 / Chapter 28 / Section 360
RCW 69.28.360: "Foreign material" defined.
Status: in_force

The term "foreign material" means pollen, wax particles, insects, or materials not deposited by bees.
RCW 69.70.030 — Washington Code / Title 69 / Chapter 70 / Section 030
RCW 69.70.030: Immunity—Eligibility.
Status: in_force

To be eligible for the immunity in RCW 69.70.070 , a person distributing donated prescription drugs under this chapter must: (1) Meet all requirements in RCW 69.70.050 and any applicable rules related to the return or exchange of prescription drugs or supplies adopted by the *board of pharmacy; (2) Maintain records of any prescription drugs and supplies donated to the pharmacy and subsequently dispensed by the pharmacy; and (3) Identify itself to the public as participating in this chapter.
RCW 69.25.140 — Washington Code / Title 69 / Chapter 25 / Section 140
RCW 69.25.140: Records required, access to and copying of.
Status: in_force

For the purpose of enforcing the provisions of this chapter and the regulations promulgated thereunder, all persons engaged in the business of transporting, shipping, or receiving any eggs or egg products in intrastate commerce or in interstate commerce, or holding such articles so received, and all egg handlers, shall maintain such records showing, for such time and in such form and manner, as the director may prescribe, to the extent that they are concerned therewith, the receipt, delivery, sale, movement, and disposition of all eggs and egg products handled by them, and shall, upon the request of the director, permit him or her at reasonable times to have access to and to copy all such records.
RCW 69.60.901 — Washington Code / Title 69 / Chapter 60 / Section 901
RCW 69.60.901: Effective date—1993 c 135.
Status: in_force

This act is necessary for the immediate preservation of the public peace, health, or safety, or support of the state government and its existing public institutions, and shall take effect immediately [April 30, 1993].
RCW 69.41.330 — Washington Code / Title 69 / Chapter 41 / Section 330
RCW 69.41.330: Public warnings—School districts.
Status: in_force

The superintendent of public instruction shall develop and distribute to all school districts signs of appropriate design and dimensions advising students of the health risks that steroids present when used solely to enhance athletic ability, and of the penalties for their unlawful possession provided by RCW 69.41.300 through 69.41.350 . School districts shall post or cause the signs to be posted in a prominent place for ease of viewing on the premises of school athletic departments.
RCW 69.10.025 — Washington Code / Title 69 / Chapter 10 / Section 025
RCW 69.10.025: Application for renewal of license after expiration date—Additional fee.
Status: in_force

If the application for renewal of any license provided for under this chapter is not filed prior to the expiration date as established by rule by the director, an additional fee of ten percent of the cost of the license shall be assessed and added to the original fee and must be paid by the applicant before the renewal license is issued.
RCW 69.77.020 — Washington Code / Title 69 / Chapter 77 / Section 020
RCW 69.77.020: Definitions.
Status: in_force

The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1) "Eligible patient" means an individual who meets the requirements of RCW 69.77.040 . (2) "Health care facility" means a clinic, nursing home, laboratory, office, or similar place where a health care provider provides health care to patients. (3) "Hospital" means a health care institution licensed under chapter 70.41 , 71.12, or 72.23 RCW. (4) "Investigational product" means a drug, biological product, or device that has successfully completed phase one and is currently in a subsequent phase of a clinical trial approved by the United States food and drug administration assessing the safety of the drug, biological product, or device under section 505 of the federal food, drug, and cosmetic act, 21 U.S.C. Sec. 355. (5) "Issuer" means any state purchased health care programs under chapter 41.05 or 74.09 RCW, a disability insurer regulated under chapter 48.20 or 48.21 RCW, a health care service contractor as defined in RCW 48.44.010 , or a health maintenance organization as defined in RCW 48.46.020 . (6) "Manufacturer" means a person or other entity engaged in the manufacture or distribution of drugs, biological products, or devices. (7) "Physician" means a physician licensed under chapter 18.71 RCW or an osteopathic physician and surgeon licensed under chapter 18.57 RCW. (8) "Serious or immediately life-threatening disease or condition" means a stage of disease in which there is reasonable likelihood that death will occur within six months or in which premature death is likely without early treatment.
RCW 69.38.020 — Washington Code / Title 69 / Chapter 38 / Section 020
RCW 69.38.020: Exemptions from chapter.
Status: in_force

All substances regulated under chapters 15.58 , 17.21, 69.04, 69.41, and 69.50 RCW, and chapter 69.45 RCW are exempt from the provisions of this chapter.
RCW 69.05.020 — Washington Code / Title 69 / Chapter 05 / Section 020
RCW 69.05.020: Sales of cosmetics tested on animals—Prohibited.
Status: in_force

Beginning January 1, 2025, it is unlawful for a manufacturer to sell or offer for sale in this state a cosmetic if the cosmetic was developed or manufactured using cosmetic animal testing that was conducted or contracted for by the manufacturer or any supplier of the manufacturer.
RCW 69.48.170 — Washington Code / Title 69 / Chapter 48 / Section 170
RCW 69.48.170: Public disclosure.
Status: in_force

Proprietary information submitted to the department under this chapter is exempt from public disclosure under RCW 42.56.270 . The department may use and disclose such information in summary or aggregated form that does not directly or indirectly identify financial, production, or sales data of an individual covered manufacturer or drug take-back organization.
RCW 69.51.060 — Washington Code / Title 69 / Chapter 51 / Section 060
RCW 69.51.060: Sources and distribution of cannabis.
Status: in_force

(1) The commission shall obtain cannabis through whatever means it deems most appropriate and consistent with regulations promulgated by the United States food and drug administration, the drug enforcement agency, and the national institute on drug abuse, and pursuant to the provisions of this chapter. (2) The commission may use cannabis which has been confiscated by local or state law enforcement agencies and has been determined to be free from contamination. (3) The commission shall distribute the analyzed cannabis to approved practitioners and/or institutions in accordance with rules promulgated by the commission.
RCW 69.05.040 — Washington Code / Title 69 / Chapter 05 / Section 040
RCW 69.05.040: Sales of cosmetics tested on animals—Prohibition application.
Status: in_force

RCW 69.05.020 does not apply to: (1) A cosmetic if the cosmetic in its final form was tested on animals before January 1, 2025, even if the cosmetic is manufactured on or after January 1, 2025, if no new animal testing in violation of this chapter occurs after January 1, 2025, by or on behalf of the manufacturer; (2) An ingredient in a cosmetic if the ingredient was tested on animals before January 1, 2025, even if the ingredient is manufactured on or after January 1, 2025, if no new animal testing in violation of this chapter occurs after January 1, 2025, by or on behalf of the manufacturer; or (3) A cosmetic manufacturer reviewing, assessing, or retaining evidence from a cosmetic animal test.
RCW 69.50.560 — Washington Code / Title 69 / Chapter 50 / Section 560
RCW 69.50.560: Controlled purchase programs—Persons under age twenty-one—Violation—Criminal penalty—Exceptions.
Status: in_force

(1) The board may conduct controlled purchase programs to determine whether: (a) A cannabis retailer is unlawfully selling cannabis to persons under the age of twenty-one; (b) A cannabis retailer holding a medical cannabis endorsement is selling to persons under the age of eighteen or selling to persons between the ages of eighteen and twenty-one who do not hold valid recognition cards; or (c) A cooperative organized under RCW 69.51A.250 is permitting a person under the age of twenty-one to participate. (2) Every person under the age of twenty-one years who purchases or attempts to purchase cannabis is guilty of a violation of this section. This section does not apply to: (a) Persons between the ages of eighteen and twenty-one who hold valid recognition cards and purchase cannabis at a cannabis retail outlet holding a medical cannabis endorsement; (b) Persons between the ages of eighteen and twenty-one years who are participating in a controlled purchase program authorized by the board under rules adopted by the board. Violations occurring under a private, controlled purchase program authorized by the board may not be used for criminal or administrative prosecution. (3) A cannabis retailer who conducts an in-house controlled purchase program authorized under this section shall provide his or her employees a written description of the employer's in-house controlled purchase program. The written description must include notice of actions an employer may take as a consequence of an employee's failure to comply with company policies regarding the sale of cannabis during an in-house controlled purchase program. (4) An in-house controlled purchase program authorized under this section shall be for the purposes of employee training and employer self-compliance checks. A cannabis retailer may not terminate an employee solely for a first-time failure to comply with company policies regarding the sale of cannabis during an in-house controlled purchase program authorized under this section. (5) Every person between the ages of eighteen and twenty-one who is convicted of a violation of this section is guilty of a misdemeanor punishable as provided by RCW 9A.20.021 .
RCW 69.05.010 — Washington Code / Title 69 / Chapter 05 / Section 010
RCW 69.05.010: Definitions.
Status: in_force

The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1)(a) "Cosmetic" means articles intended: (i) To be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance; or (ii) For use as a component of any articles under (a)(i) of this subsection. (b) "Cosmetic" does not include soap. (2) "Cosmetic animal testing" means the internal or external application or exposure of any cosmetic product, or any cosmetic ingredient or nonfunctional constituent, to the skin, eyes, or any other body part of a live, nonhuman vertebrate. (3) "Cosmetic ingredient" means any single chemical entity or mixture used as a component in the manufacture of a cosmetic product, as defined in 21 C.F.R. Sec. 700.3(e) on January 1, 2025. (4) "Cosmetic product" means a finished cosmetic, the manufacture of which has been completed. (5) "Manufacture" has the same meaning as "to manufacture" in RCW 82.04.120 . (6) "Manufacturer" means any entity required to specify conspicuously its name and place of business on the label of a cosmetic in package form under 21 C.F.R. Sec. 701.12 on January 1, 2025. (7) "Nonfunctional constituent" means any incidental ingredient as defined in 21 C.F.R. Sec. 701.3(1) on January 1, 2025. (8) "Supplier" means any entity that provides, whether directly or through a third party, any cosmetic ingredient used by a manufacturer in the formulation of a cosmetic product.
RCW 69.43.190 — Washington Code / Title 69 / Chapter 43 / Section 190
RCW 69.43.190: Products found at methamphetamine sites—Report.
Status: in_force

Each county sheriff shall compile and maintain a record of commercial products containing ephedrine, pseudoephedrine, or phenylpropanolamine and packaging found at methamphetamine laboratory sites. The data shall be forwarded to the Washington association of sheriffs and police chiefs and shall be reported to the legislature by November 1, 2007, and annually thereafter.
RCW 69.04.460 — Washington Code / Title 69 / Chapter 04 / Section 460
RCW 69.04.460: Packaged drugs—Misbranding.
Status: in_force

If a drug or device is in package form, it shall be deemed to be misbranded unless it bears a label containing (1) the name and place of business of the manufacturer, packer, or distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count: PROVIDED, That under clause (2) of this section reasonable variations shall be permitted, and exemptions as to small packages shall be established, by regulations promulgated by the director.
RCW 69.04.720 — Washington Code / Title 69 / Chapter 04 / Section 720
RCW 69.04.720: Advertising of cure of certain diseases deemed false.
Status: in_force

The advertisement of a drug or device representing it to have any effect in albuminuria, appendicitis, arteriosclerosis, blood poison, bone disease, Bright's disease, cancer, carbuncles, cholecystitis, diabetes, diphtheria, dropsy, erysipelas, gallstones, heart and vascular diseases, high blood pressure, mastoiditis, measles, meningitis, mumps, nephritis, otitis media, paralysis, pneumonia, poliomyelitis (infantile paralysis), prostate gland disorders, pyelitis, scarlet fever, sexual impotence, sinus infection, smallpox, tuberculosis, tumors, typhoid, uremia, *venereal disease, shall also be deemed to be false; except that no advertisement not in violation of RCW 69.04.710 shall be deemed to be false under this section if it is disseminated only to members of the medical, veterinary, dental, pharmacal, and other legally recognized professions dealing with the healing arts, or appears only in the scientific periodicals of these professions, or is disseminated only for the purpose of public health education by persons not commercially interested, directly or indirectly, in the sale of such drugs or devices: PROVIDED, That whenever the director determines that an advance in medical science has made any type of self-medication safe as to any of the diseases named above, the director shall by regulation authorize the advertisement of drugs having curative or therapeutic effect for such disease, subject to such conditions and restrictions as the director may deem necessary in the interest of public health: PROVIDED FURTHER, That this section shall not be construed as indicating that self-medication for diseases other than those named herein is safe or efficacious.
RCW 69.41.130 — Washington Code / Title 69 / Chapter 41 / Section 130
RCW 69.41.130: Savings in price to be passed on to purchaser.
Status: in_force

Unless the brand name drug is requested by the patient or the patient's representative, the pharmacist shall substitute an equivalent drug product which he or she has in stock if its wholesale price to the pharmacist is less than the wholesale price of the prescribed drug product, and at least sixty percent of the savings shall be passed on to the purchaser.
RCW 69.48.080 — Washington Code / Title 69 / Chapter 48 / Section 080
RCW 69.48.080: Disposal and handling of covered drugs.
Status: in_force

(1) Covered drugs collected under a drug take-back program must be disposed of at a permitted hazardous waste disposal facility that meets the requirements of 40 C.F.R. parts 264 and 265, as they exist on June 7, 2018. (2) If use of a hazardous waste disposal facility described in subsection (1) of this section is unfeasible based on cost, logistics, or other considerations, the department, in consultation with the department of ecology, may grant approval for a program operator to dispose of some or all collected covered drugs at a permitted large municipal waste combustor facility that meets the requirements of 40 C.F.R. parts 60 and 62, as they exist on June 7, 2018. (3) A program operator may petition the department for approval to use final disposal technologies or processes that provide superior environmental and human health protection than that provided by the technologies described in subsections (1) and (2) of this section, or equivalent protection at less cost. In reviewing a petition under this subsection, the department shall take into consideration regulations or guidance issued by the United States environmental protection agency on the disposal of pharmaceutical waste. The department, in consultation with the department of ecology, shall approve a disposal petition under this section if the disposal technology or processes described in the petition provides equivalent or superior protection in each of the following areas: (a) Monitoring of any emissions or waste; (b) Worker health and safety; (c) Air, water, or land emissions contributing to persistent, bioaccumulative, and toxic pollution; and (d) Overall impact to the environment and human health. (4) If a drug take-back program encounters a safety or security problem during collection, transportation, or disposal of covered drugs, the program operator must notify the department as soon as practicable after encountering the problem.
RCW 69.51A.210 — Washington Code / Title 69 / Chapter 51A / Section 210
RCW 69.51A.210: Qualifying patients or designated providers—Authorization—Health care professional may include recommendations on amount of cannabis.
Status: in_force

As part of authorizing a qualifying patient or designated provider, the health care professional may include recommendations on the amount of cannabis that is likely needed by the qualifying patient for his or her medical needs and in accordance with this section. (1) If the health care professional does not include recommendations on the qualifying patient's or designated provider's authorization, the cannabis retailer with a medical cannabis endorsement, when adding the qualifying patient or designated provider to the medical cannabis authorization database, shall enter into the database that the qualifying patient or designated provider may purchase or obtain at a retail outlet holding a medical cannabis endorsement a combination of the following: Forty-eight ounces of cannabis-infused product in solid form; three ounces of useable cannabis; two hundred sixteen ounces of cannabis-infused product in liquid form; or twenty-one grams of cannabis concentrates. The qualifying patient or designated provider may also grow, in his or her domicile, up to six plants for the personal medical use of the qualifying patient and possess up to eight ounces of useable cannabis produced from his or her plants. These amounts shall be specified on the recognition card that is issued to the qualifying patient or designated provider. (2) If the health care professional determines that the medical needs of a qualifying patient exceed the amounts provided for in subsection (1) of this section, the health care professional must specify on the authorization that it is recommended that the patient be allowed to grow, in his or her domicile, up to fifteen plants for the personal medical use of the patient. A patient so authorized may possess up to sixteen ounces of useable cannabis in his or her domicile. The number of plants must be entered into the medical cannabis authorization database by the cannabis retailer with a medical cannabis endorsement and specified on the recognition card that is issued to the qualifying patient or designated provider. (3) If a qualifying patient or designated provider with an authorization from a health care professional has not been entered into the medical cannabis authorization database, he or she may not receive a recognition card and may only purchase at a retail outlet, whether it holds a medical cannabis endorsement or not, the amounts established in RCW 69.50.360 . In addition the qualifying patient or the designated provider may grow, in his or her domicile, up to four plants for the personal medical use of the qualifying patient and possess up to six ounces of useable cannabis in his or her domicile.
RCW 69.04.600 — Washington Code / Title 69 / Chapter 04 / Section 600
RCW 69.04.600: Denial of application.
Status: in_force

If the director finds, upon the basis of the information before him or her and after due notice and opportunity for hearing to the applicant, that the drug, subject to the application, is not safe for use under the conditions prescribed, recommended, or suggested in the labeling thereof, he or she shall, prior to such effective date, issue an order refusing to permit such application to become effective and stating the findings upon which it is based.
RCW 69.04.790 — Washington Code / Title 69 / Chapter 04 / Section 790
RCW 69.04.790: Owner may obtain part of sample.
Status: in_force

Where a sample or specimen of any such article is taken for examination under this chapter, the director shall, upon request, provide a part thereof for examination by any person named on the label of such article, or the owner thereof, or his or her attorney or agent; except that the director is authorized, by regulation, to make such reasonable exceptions from, and to impose such reasonable terms and conditions relating to, the operation of this section as he or she finds necessary for the proper administration of the provisions of this chapter.
RCW 69.70.110 — Washington Code / Title 69 / Chapter 70 / Section 110
RCW 69.70.110: Prescription drug donation—Rules.
Status: in_force

The pharmacy quality assurance commission may adopt rules to allow the safe donation of prescription drugs under this chapter including, but not limited to, allowing pharmacy to pharmacy donation of unexpired prescription drug stock.
RCW 69.50.304 — Washington Code / Title 69 / Chapter 50 / Section 304
RCW 69.50.304: Denial and discipline of registration—Seizure or placement under seal of controlled substances.
Status: in_force

(1) This chapter and chapter 18.64 RCW govern the denial of registrations and the discipline of registrations issued under RCW 69.50.303 . The uniform disciplinary act, chapter 18.130 RCW, governs unlicensed practice of persons required to obtain a registration under this chapter. (2) In addition to any other grounds, the commission may take action against the registration, or exemption from registration, under RCW 69.50.303 to manufacture, distribute, dispense, or conduct research with a controlled substance upon finding that the registrant has: (a) furnished false or fraudulent material information in any application filed under this chapter; (b) been convicted of a felony under any state or federal law relating to any controlled substance; (c) had the registrant's federal registration suspended or revoked and is no longer authorized by federal law to manufacture, distribute, dispense, or conduct research with controlled substances; or (d) committed acts that would render registration under RCW 69.50.303 inconsistent with the public interest as determined under that section. (3) The commission may limit revocation or suspension of a registration to the particular controlled substance or schedule of controlled substances, with respect to which grounds for revocation or suspension exist. (4) If the commission suspends or revokes a registration, all controlled substances owned or possessed by the registrant at the time of suspension or the effective date of the revocation order may be placed under seal. No disposition may be made of substances under seal until the time for taking an appeal has elapsed or until all appeals have been concluded unless a court, upon application, orders the sale of perishable substances and the deposit of the proceeds of the sale with the court. Upon a revocation order becoming final, all controlled substances may be forfeited to the state. (5) The commission may seize or place under seal any controlled substance owned or possessed by a registrant whose registration has expired or who has ceased to practice or do business in the manner contemplated by the registration. The controlled substance must be held for the benefit of the registrant or the registrant's successor in interest. The commission shall notify a registrant, or the registrant's successor in interest, who has any controlled substance seized or placed under seal, of the procedures to be followed to secure the return of the controlled substance and the conditions under which it will be returned. The commission may not dispose of any controlled substance seized or placed under seal under this subsection until the expiration of 180 days after the controlled substance was seized or placed under seal. The costs incurred by the commission in seizing, placing under seal, maintaining custody, and disposing of any controlled substance under this subsection may be recovered from the registrant, any proceeds obtained from the disposition of the controlled substance, or from both. Any balance remaining after the costs have been recovered from the proceeds of any disposition must be delivered to the registrant or the registrant's successor in interest. (6) The commission shall promptly notify the drug enforcement administration of all orders restricting, suspending, or revoking registration and all forfeitures of controlled substances.
RCW 69.45.050 — Washington Code / Title 69 / Chapter 45 / Section 050
RCW 69.45.050: Distribution of drug samples—Written request—No fee or charge permitted—Possession of legend drugs or controlled substances by manufacturers' representatives.
Status: in_force

(1) Drug samples may be distributed by a manufacturer or a manufacturer's representative only to practitioners legally authorized to prescribe such drugs or, at the request of such practitioner, to pharmacies of hospitals or other health care entities. The recipient of the drug sample must execute a written receipt upon delivery that is returned to the manufacturer or the manufacturer's representative. (2) Drug samples may be distributed by a manufacturer or a manufacturer's representative only to a practitioner legally authorized to prescribe such drugs pursuant to a written request for such samples. The request shall contain: (a) The recipient's name, address, and professional designation; (b) The name, strength, and quantity of the drug samples delivered; (c) The name or identification of the manufacturer and of the individual distributing the drug sample; and (d) The dated signature of the practitioner requesting the drug sample. (3) No fee or charge may be imposed for sample drugs distributed in this state. (4) A manufacturer's representative shall not possess legend drugs or controlled substances other than those distributed by the manufacturer they represent. Nothing in this section prevents a manufacturer's representative from possessing a legally prescribed and dispensed legend drug or controlled substance.
RCW 69.07.220 — Washington Code / Title 69 / Chapter 07 / Section 220
RCW 69.07.220: Hemp extract certification.
Status: in_force

(1) Until such time as hemp extract is federally authorized for use as a food ingredient, hemp extract is not an approved food ingredient in Washington state. A hemp processor who wishes to engage in the production of hemp extract for use as a food ingredient in another state that allows its use as a food ingredient may apply for a hemp extract certification to certify the hemp processor's compliance with Washington's inspection and good manufacturing practices requirements. The department shall regulate hemp extract processing the same as other food processing under chapters 15.130 , 69.07, and 69.22 RCW with the exceptions contained in subsections (2) through (6) of this section. (2) The department's oversight is limited to certifying a hemp processor's compliance with applicable inspection and good manufacturing practices requirements as adopted by the department under chapter 15.130 RCW. (3) The department must issue a hemp extract certification in lieu of a food processing license under RCW 69.07.040 to a hemp processor who meets the application requirements described in subsection (4) of this section. A hemp processor holding a hemp extract certification must apply for renewal of the certification annually. (4) The application, initial certification, and renewal fees must be in an amount established by the department. Applicants for certification otherwise must meet the same requirements as applicants for a food processing license under chapter 69.07 RCW including, but not limited to, successful completion of an inspection by the department. (5) The department may deny, suspend, or revoke a hemp extract certification on the same grounds as the department may deny, suspend, or revoke a food processor's license under this chapter. (6) At such time as federal authorization of hemp extracts as a food ingredient occurs, the department must cease issuance of certifications under this chapter. At renewal, hemp processors certified under this section must apply for a food processor license in accordance with RCW 69.07.040 .
RCW 15.30.010 — Washington Code / Title 69 / Chapter 30 / Section 010
RCW 15.30.010: Definitions.
Status: in_force

For the purpose of this chapter: (1) "Department" means the department of agriculture of the state of Washington. (2) "Director" means the director of the department or his or her duly appointed representative. (3) "Person" means a natural person, individual, or firm, partnership, corporation, company, society, and association and every officer, agent, or employee thereof. This term shall import either the singular or plural, as the case may be. (4) "Controlled atmosphere storage" means any storage warehouse consisting of one or more rooms, or one or more rooms in any one facility in which atmospheric gases are controlled in their amount and in degrees of temperature for the purpose of controlling the condition and maturity of any fresh fruits or vegetables in order that, upon removal, they may be designated as having been exposed to controlled atmosphere.The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1) "Approved shellfish tag or label" means a tag or label meeting the requirements of the national shellfish sanitation program model ordinance. (2) "Commercial quantity" means any quantity exceeding: (a) Forty pounds of mussels; (b) one hundred oysters; (c) fourteen horse clams; (d) six geoducks; (e) fifty pounds of hard or soft shell clams; or (f) fifty pounds of scallops. The poundage in this subsection (2) constitutes weight with the shell. (3) "Department" means the state department of health. (4) "Establishment" means the buildings, together with the necessary equipment and appurtenances, used for the storage, culling, shucking, packing and/or shipping of shellfish in commercial quantity or for sale for human consumption. (5) "Ex officio fish and wildlife officer" means an ex officio fish and wildlife officer as defined in RCW 77.08.010 . (6) "Fish and wildlife officer" means a fish and wildlife officer as defined in RCW 77.08.010 . (7) "Person" means any individual, partnership, firm, company, corporation, association, or the authorized agents of any such entities. (8) "Sale" means to sell, offer for sale, barter, trade, deliver, consign, hold for sale, consignment, barter, trade, or delivery, and/or possess with intent to sell or dispose of in any commercial manner. (9) "Secretary" means the secretary of health or his or her authorized representatives. (10) "Shellfish" means all varieties of fresh and frozen oysters, mussels, clams, and scallops, either shucked or in the shell, and any fresh or frozen edible products thereof. (11) "Shellfish growing areas" means the lands and waters in and upon which shellfish are grown for harvesting in commercial quantity or for sale for human consumption. (12) "Shellstock" means live molluscan shellfish in the shell.
RCW 69.04.850 — Washington Code / Title 69 / Chapter 04 / Section 850
RCW 69.04.850: Construction—1945 c 257.
Status: in_force

This chapter and the rules adopted hereunder shall be so interpreted and construed as to effectuate its general purpose to secure uniformity with federal acts and regulations relating to adulterating, misbranding and false advertising of drugs, devices, and cosmetics.
RCW 69.41.170 — Washington Code / Title 69 / Chapter 41 / Section 170
RCW 69.41.170: Coercion of pharmacist prohibited—Penalty.
Status: in_force

It shall be unlawful for any employer to coerce, within the meaning of RCW 9A.36.070 , any pharmacist to dispense a generic drug or to substitute a generic drug for another drug. A violation of this section shall be punishable as a misdemeanor.
RCW 69.50.363 — Washington Code / Title 69 / Chapter 50 / Section 363
RCW 69.50.363: Cannabis processors, employees—Certain acts not criminal or civil offenses.
Status: in_force

The following acts, when performed by a validly licensed cannabis processor or employee of a validly licensed cannabis processor in compliance with rules adopted by the board to implement and enforce chapter 3, Laws of 2013, do not constitute criminal or civil offenses under Washington state law: (1) Purchase and receipt of cannabis that has been properly packaged and labeled from a cannabis producer validly licensed under chapter 3, Laws of 2013; (2) Possession, processing, packaging, and labeling of quantities of cannabis, useable cannabis, and cannabis-infused products that do not exceed the maximum amounts established by the board under RCW 69.50.345 (4); (3) Delivery, distribution, and sale of useable cannabis or cannabis-infused products to a cannabis retailer validly licensed under chapter 3, Laws of 2013; and (4) Delivery, distribution, and sale of useable cannabis, cannabis concentrates, or cannabis-infused products to a federally recognized Indian tribe as permitted under an agreement between the state and the tribe entered into under RCW 43.06.490 .
RCW 69.25.010 — Washington Code / Title 69 / Chapter 25 / Section 010
RCW 69.25.010: Legislative finding.
Status: in_force

Eggs and egg products are an important source of the state's total supply of food, and are used in food in various forms. They are consumed throughout the state and the major portion thereof moves in intrastate commerce. It is essential, in the public interest, that the health and welfare of consumers be protected by the adoption of measures prescribed herein for assuring that eggs and egg products distributed to them and used in products consumed by them are wholesome, otherwise not adulterated, and properly labeled and packaged. Lack of effective regulation for the handling or disposition of unwholesome, otherwise adulterated, or improperly labeled or packaged egg products and certain qualities of eggs is injurious to the public welfare and destroys markets for wholesome, unadulterated, and properly labeled and packaged eggs and egg products and results in sundry losses to producers and processors, as well as injury to consumers. Unwholesome, otherwise adulterated, or improperly labeled or packaged products can be sold at lower prices and compete unfairly with the wholesome, unadulterated, and properly labeled and packaged products, to the detriment of consumers and the public generally. It is also essential to protect the health and welfare of consumers, promote food safety, advance animal welfare, and protect against the negative fiscal effects on the state associated with the lack of effective regulation of egg production and sales. It is hereby found that all egg products and the qualities of eggs which are regulated under this chapter are either in intrastate commerce, or substantially affect such commerce, and that regulation by the director, as contemplated by this chapter, is appropriate to protect the health and welfare of consumers.
RCW 69.25.080 — Washington Code / Title 69 / Chapter 25 / Section 080
RCW 69.25.080: Continuous inspection at processing plants—Exemptions—Condemnation and destruction of adulterated eggs and egg products—Reprocessing—Appeal—Inspections of egg handlers.
Status: in_force

(1) For the purpose of preventing the entry into or movement in intrastate commerce of any egg product which is capable of use as human food and is misbranded or adulterated, the director shall, whenever processing operations are being conducted, unless under inspection by the United States department of agriculture, cause continuous inspection to be made, in accordance with the regulations promulgated under this chapter, of the processing of egg products, in each plant processing egg products for commerce, unless exempted under RCW 69.25.170 . Without restricting the application of the preceding sentence to other kinds of establishments within its provisions, any food manufacturing establishment, institution, or restaurant which uses any eggs that do not meet the requirements of RCW 69.25.170 (1)(a) in the preparation of any articles for human food, shall be deemed to be a plant processing egg products, with respect to such operations. (2) The director, at any time, shall cause such retention, segregation, and reinspection as he or she deems necessary of eggs and egg products capable of use as human food in each official plant. (3) Eggs and egg products found to be adulterated at official plants shall be condemned, and if no appeal be taken from such determination or condemnation, such articles shall be destroyed for human food purposes under the supervision of an inspector: PROVIDED, That articles which may by reprocessing be made not adulterated need not be condemned and destroyed if so reprocessed under the supervision of an inspector and thereafter found to be not adulterated. If an appeal be taken from such determination, the eggs or egg products shall be appropriately marked and segregated pending completion of an appeal inspection, which appeal shall be at the cost of the appellant if the director determines that the appeal is frivolous. If the determination of condemnation is sustained, the eggs or egg products shall be destroyed for human food purposes under the supervision of an inspector. (4) The director shall cause such other inspections to be made of the business premises, facilities, inventory, operations, and records of egg handlers, and the records and inventory of other persons required to keep records under RCW 69.25.140 , as he or she deems appropriate (and in the case of shell egg packers, packing eggs for the ultimate consumer, at least once each calendar quarter) to assure that only eggs fit for human food are used for such purpose, and otherwise to assure compliance by egg handlers and other persons with the requirements of RCW 69.25.140 , except that the director shall cause such inspections to be made as he or she deems appropriate to assure compliance with such requirements at food manufacturing establishments, institutions, and restaurants, other than plants processing egg products. Representatives of the director shall be afforded access to all such places of business for purposes of making the inspections provided for in this chapter.
RCW 69.77.010 — Washington Code / Title 69 / Chapter 77 / Section 010
RCW 69.77.010: Findings—Intent.
Status: in_force

The legislature finds that the process for approval of investigational drugs, biological products, and devices in the United States protects future patients from premature, ineffective, and unsafe medications and treatments over time, but the process often takes many years. Patients who have a terminal illness do not have the luxury of waiting until an investigational drug, biological product, or device receives final approval from the United States food and drug administration. The legislature further finds that patients who have a terminal illness should be permitted to pursue the preservation of their own lives by accessing available investigational drugs, biological products, and devices. The use of available investigational drugs, biological products, and devices is a decision that should be made by the patient with a terminal illness in consultation with the patient's health care provider so that the decision to use an investigational drug, biological product, or device is made with full awareness of the potential risks, benefits, and consequences to the patient and the patient's family. The legislature, therefore, intends to allow terminally ill patients to use potentially lifesaving investigational drugs, biological products, and devices.
RCW 69.43.150 — Washington Code / Title 69 / Chapter 43 / Section 150
RCW 69.43.150: Application of chapter to local government.
Status: in_force

This chapter is applicable and uniform throughout this state and in all counties, cities, code cities, and towns therein. A county, city, code city, or town may not adopt or enforce any ordinance, pertaining to this chapter, which prohibits conduct that is not prohibited under this chapter, or defining violations or penalties different from those provided under this chapter. However, this section does not preclude a county, city, code city, or town from revoking, canceling, suspending, or otherwise limiting a business or professional license it has issued for conduct that violates any provision of this chapter.
RCW 69.05.060 — Washington Code / Title 69 / Chapter 05 / Section 060
RCW 69.05.060: Penalty.
Status: in_force

A manufacturer that sells or offers for sale a cosmetic in violation of this chapter commits a civil violation punishable by a fine of not more than $5,000 for each violation.
RCW 69.52.030 — Washington Code / Title 69 / Chapter 52 / Section 030
RCW 69.52.030: Violations—Exceptions.
Status: in_force

(1) It is unlawful for any person to manufacture, distribute, or possess with intent to distribute, an imitation controlled substance. Any person who violates this subsection shall, upon conviction, be guilty of a class C felony. (2) Any person eighteen years of age or over who violates subsection (1) of this section by distributing an imitation controlled substance to a person under eighteen years of age is guilty of a class B felony. (3) It is unlawful for any person to cause to be placed in any newspaper, magazine, handbill, or other publication, or to post or distribute in any public place, any advertisement or solicitation offering for sale imitation controlled substances. Any person who violates this subsection is guilty of a class C felony. (4) No civil or criminal liability shall be imposed by virtue of this chapter on any person registered under the Uniform Controlled Substances Act pursuant to RCW 69.50.301 or 69.50.303 who manufactures, distributes, or possesses an imitation controlled substance for use as a placebo or other use by a registered practitioner, as defined in RCW 69.50.101 , in the course of professional practice or research. (5) No prosecution under this chapter shall be dismissed solely by reason of the fact that the dosage units were contained in a bottle or other container with a label accurately describing the ingredients of the imitation controlled substance dosage units. The good faith of the defendant shall be an issue of fact for the trier of fact.
RCW 69.77.080 — Washington Code / Title 69 / Chapter 77 / Section 080
RCW 69.77.080: Private right of action—Unprofessional conduct—Immunity from civil or criminal liability.
Status: in_force

(1) Chapter 212, Laws of 2017 does not create a private right of action. (2) A health care practitioner does not commit unprofessional conduct under RCW 18.130.180 and does not violate the applicable standard of care by: (a) Obtaining an investigational product pursuant to this chapter; (b) Refusing to recommend, request, prescribe, or otherwise provide an investigational product pursuant to this chapter; (c) Administering an investigational product to an eligible patient pursuant to this chapter; or (d) Treating an eligible patient with an investigational product pursuant to this chapter. (3) The following persons and entities are immune from civil or criminal liability and administrative actions arising out of treatment of an eligible patient with an investigational product, other than acts or omissions constituting gross negligence or willful or wanton misconduct: (a) A health care practitioner who recommends or requests an investigational product for an eligible patient in compliance with this chapter; (b) A health care practitioner who refuses to recommend or request an investigational product for a patient seeking access to an investigational product; (c) A manufacturer that provides an investigational product to a health care practitioner in compliance with this chapter; (d) A hospital or health care facility where an investigational product is either administered or provided to an eligible patient in compliance with this chapter; and (e) A hospital or health care facility that does not allow a health care practitioner to provide treatment with an investigational product or enforces a policy it has adopted regarding treating, administering, or providing care with an investigational product.
RCW 69.25.110 — Washington Code / Title 69 / Chapter 25 / Section 110
RCW 69.25.110: Prohibited acts and practices.
Status: in_force

(1) No person shall buy, sell, or transport, or offer to buy or sell, or offer or receive for transportation, in any business in intrastate commerce any restricted eggs, capable of use as human food, except as authorized by regulations of the director under such conditions as he or she may prescribe to assure that only eggs fit for human food are used for such purpose. (2) No egg handler shall possess with intent to use, or use, any restricted eggs in the preparation of human food for intrastate commerce except that such eggs may be so possessed and used when authorized by regulations of the director under such conditions as he or she may prescribe to assure that only eggs fit for human food are used for such purpose. (3) No person shall process any egg products for intrastate commerce at any plant except in compliance with the requirements of this chapter. (4) No person shall buy, sell, or transport, or offer to buy or sell, or offer or receive for transportation, in intrastate commerce any egg or egg product that was not produced in compliance with the standards required by RCW 69.25.065 and 69.25.107 . This prohibition shall not apply to any sale undertaken at an official plant at which mandatory inspection is maintained under the federal egg products inspection act, 21 U.S.C. Sec. 1031 et seq. For the purposes of this subsection, a sale is deemed to occur at the location where the buyer takes physical possession of an item. (5) No person shall buy, sell, or transport, or offer to buy or sell, or offer or receive for transportation, in intrastate commerce any egg products required to be inspected under this chapter unless they have been so inspected and are labeled and packaged in accordance with the requirements of RCW 69.25.100 . (6) No operator of any official plant shall allow any egg products to be moved from such plant if they are adulterated or misbranded and capable of use as human food. (7) No person shall: (a) Manufacture, cast, print, lithograph, or otherwise make any device containing any official mark or simulation thereof, or any label bearing any such mark or simulation, or any form of official certificate or simulation thereof, except as authorized by the director; (b) Forge or alter any official device, mark, or certificate; (c) Without authorization from the director, use any official device, mark, or certificate, or simulation thereof, or detach, deface, or destroy any official device or mark; or use any labeling or container ordered to be withheld from use under RCW 69.25.100 after final judicial affirmance of such order or expiration of the time for appeal if no appeal is taken under said section; (d) Contrary to the regulations prescribed by the director, fail to use, or to detach, deface, or destroy any official device, mark, or certificate; (e) Knowingly possess, without promptly notifying the director or his or her representative, any official device or any counterfeit, simulated, forged, or improperly altered official certificate or any device or label, or any eggs or egg products bearing any counterfeit, simulated, forged, or improperly altered official mark; (f) Knowingly make any false statement in any shipper's certificate or other nonofficial or official certificate provided for in the regulations prescribed by the director; (g) Knowingly represent that any article has been inspected or exempted, under this chapter when in fact it has not been so inspected or exempted; and (h) Refuse access, at any reasonable time, to any representative of the director, to any plant or other place of business subject to inspection under any provisions of this chapter. (8) No person, while an official or employee of the state or local governmental agency, or thereafter, shall use to his or her own advantage, or reveal other than to the authorized representatives of the United States government or the state in their official capacity, or as ordered by a court in a judicial proceeding, any information acquired under the authority of this chapter concerning any matter which the originator or relator of such information claims to be entitled to protection as a trade secret.
RCW 69.50.209 — Washington Code / Title 69 / Chapter 50 / Section 209
RCW 69.50.209: Schedule IV tests.
Status: in_force

(a) [(1)] The commission shall place a substance in Schedule IV upon finding that: (1) [(a)] the substance has a low potential for abuse relative to substances in Schedule III; (2) [(b)] the substance has currently accepted medical use in treatment in the United States; and (3) [(c)] abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances included in Schedule III. (b) [(2)] The commission may place a substance in Schedule IV without making the findings required by subsection (a) [(1)] of this section if the substance is controlled under Schedule IV of the federal Controlled Substances Act by a federal agency as the result of an international treaty, convention, or protocol.
RCW 69.50.501 — Washington Code / Title 69 / Chapter 50 / Section 501
RCW 69.50.501: Administrative inspections.
Status: in_force

The commission may make administrative inspections of controlled premises in accordance with the following provisions: (1) For purposes of this section only, "controlled premises" means: (a) places where persons registered or exempted from registration requirements under this chapter are required to keep records; and (b) places including factories, warehouses, establishments, and conveyances in which persons registered or exempted from registration requirements under this chapter are permitted to hold, manufacture, compound, process, sell, deliver, or otherwise dispose of any controlled substance. (2) When authorized by an administrative inspection warrant issued pursuant to RCW 69.50.502 an officer or employee designated by the commission, upon presenting the warrant and appropriate credentials to the owner, operator, or agent in charge, may enter controlled premises for the purpose of conducting an administrative inspection. (3) When authorized by an administrative inspection warrant, an officer or employee designated by the commission may: (a) inspect and copy records required by this chapter to be kept; (b) inspect, within reasonable limits and in a reasonable manner, controlled premises and all pertinent equipment, finished and unfinished material, containers and labeling found therein, and, except as provided in subsection (5) of this section, all other things therein, including records, files, papers, processes, controls, and facilities bearing on violation of this chapter; and (c) inventory any stock of any controlled substance therein and obtain samples thereof. (4) This section does not prevent the inspection without a warrant of books and records pursuant to an administrative subpoena issued in accordance with chapter 34.05 RCW, nor does it prevent entries and administrative inspections, including seizures of property, without a warrant: (a) if the owner, operator, or agent in charge of the controlled premises consents; (b) in situations presenting imminent danger to health or safety; (c) in situations involving inspection of conveyances if there is reasonable cause to believe that the mobility of the conveyance makes it impracticable to obtain a warrant; (d) in any other exceptional or emergency circumstance where time or opportunity to apply for a warrant is lacking; or, (e) in all other situations in which a warrant is not constitutionally required. (5) An inspection authorized by this section shall not extend to financial data, sales data, other than shipment data, or pricing data unless the owner, operator, or agent in charge of the controlled premises consents in writing.
RCW 69.80.031 — Washington Code / Title 69 / Chapter 80 / Section 031
RCW 69.80.031: Good samaritan food donation act—Definitions—Collecting, distributing, gleaning—Liability.
Status: in_force

(1) This section may be cited as the "good samaritan food donation act." (2) The definitions in this subsection apply throughout this section unless the context clearly requires otherwise. (a) "Apparently fit grocery product" means a grocery product that meets safety and safety-related labeling standards imposed by federal, state, and local laws and regulations even though the product may not be readily marketable due to appearance, age, freshness, grade, size, surplus, passage of a date on a date label other than a safety or safety-related labeling of a date, or other conditions. (b) "Apparently wholesome food" means food that meets safety and safety-related labeling standards imposed by federal, state, and local laws and regulations even though the food may not be readily marketable due to appearance, age, freshness, grade, size, surplus, passage of a date on a date label other than a safety or safety-related labeling of a date, or other conditions. (c) "Donate" means to give without requiring anything of monetary value from the recipient, except that the term shall include giving by a nonprofit organization to another nonprofit organization, notwithstanding that the donor organization has charged a nominal fee to the donee organization, if the ultimate recipient or user is not required to give anything of monetary value. (d) "Food" means a raw, cooked, processed, or prepared edible substance, ice, beverage, or ingredient used or intended for use in whole or in part for human consumption. (e) "Gleaner" means a person who harvests for free distribution to the needy, or for donation to a nonprofit organization for ultimate distribution to the needy, an agricultural crop that has been donated by the owner. (f) "Grocery product" means a nonfood grocery product, including a disposable paper or plastic product, household cleaning product, laundry detergent, cleaning product, or miscellaneous household item. (g) "Gross negligence" means voluntary and conscious conduct by a person with knowledge, at the time of the conduct, that the conduct is likely to be harmful to the health or well-being of another person. (h) "Intentional misconduct" means conduct by a person with knowledge, at the time of the conduct, that the conduct is harmful to the health or well-being of another person. (i) "Nonprofit organization" means an incorporated or unincorporated entity that: (i) Is operating for religious, charitable, or educational purposes; and (ii) Does not provide net earnings to, or operate in any other manner that inures to the benefit of, any officer, employee, or shareholder of the entity. (j) "Person" means an individual, corporation, partnership, organization, association, or governmental entity, including a retail grocer, wholesaler, hotel, motel, manufacturer, restaurant, caterer, farmer, and nonprofit food distributor or hospital. In the case of a corporation, partnership, organization, association, or governmental entity, the term includes an officer, director, partner, deacon, trustee, councilmember, or other elected or appointed individual responsible for the governance of the entity. (k) "Qualified direct donor" means any person required to obtain a food establishment permit under chapter 246-215 WAC, as it existed as of January 1, 2022, including a retail grocer, wholesaler, agricultural producer, restaurant, caterer, school food authority, or institution of higher education as defined in RCW 28B.10.016 . (l)(i) "Safety and safety-related labeling" means a marking intended to communicate information to a consumer related to a food product's safety. "Safety and safety-related labeling" includes any marking that federal or state law requires to be affixed to a food product including, but not limited to, markings placed on infant formula consistent with 21 C.F.R. Sec. 107.20, as that regulation existed as of January 1, 2021. (ii) "Safety and safety-related labeling" does not include a pull date required to be placed on perishable packaged food under RCW 15.130.300 or a "best by," "best if used by," "use by," or "sell by" date or similarly phrased date intended to communicate information to a consumer regarding the freshness or quality of a food product. (3)(a) A person or gleaner is not subject to civil or criminal liability arising from the nature, age, packaging, or condition of apparently wholesome food or an apparently fit grocery product that the person or gleaner donates in good faith to a nonprofit organization for ultimate distribution to needy individuals, except that this subsection does not apply to an injury to or death of an ultimate user or recipient of the food or grocery product that results from an act or omission of the donor constituting gross negligence or intentional misconduct. (b) A qualified direct donor may donate food directly to end recipients for consumption. A qualified direct donor is not subject to civil or criminal liability arising from the nature, age, packaging, or condition of apparently wholesome food or an apparently fit grocery product that the qualified direct donor donates in good faith to a needy individual. The donation of nonperishable food that is fit for human consumption, but that has exceeded the labeled shelf-life date recommended by the manufacturer, is an activity covered by the exclusion from civil or criminal liability under this section. (c) The donation of perishable food that is fit for human consumption, but that has exceeded the labeled shelf-life date recommended by the manufacturer, is an activity covered by the exclusion from civil or criminal liability under this section if the person that distributes the food to the end recipient makes a good faith evaluation that the food to be donated is wholesome. (4) A person who allows the collection or gleaning of donations on property owned or occupied by the person by gleaners, or paid or unpaid representatives of a nonprofit organization, for ultimate distribution to needy individuals is not subject to civil or criminal liability that arises due to the injury or death of the gleaner or representative, except that this subsection does not apply to an injury or death that results from an act or omission of the person constituting gross negligence or intentional misconduct. (5) If some or all of the donated food and grocery products do not meet safety and safety-related labeling standards imposed by federal, state, and local laws and regulations, the person or gleaner who donates the food and grocery products is not subject to civil or criminal liability in accordance with this section if the nonprofit organization or other end recipient that receives the donated food or grocery products: (a) Is informed by the donor of the distressed or defective condition of the donated food or grocery products; (b) Agrees to recondition the donated food or grocery products to comply with all the safety and safety-related labeling standards prior to distribution; and (c) Is knowledgeable of the standards to properly recondition the donated food or grocery product. (6) This section may not be construed to create liability.
RCW 69.04.880 — Washington Code / Title 69 / Chapter 04 / Section 880
RCW 69.04.880: Civil penalty.
Status: in_force

Whenever the director finds that a person has committed a violation of a provision of this chapter, the director may impose upon and collect from the violator a civil penalty not exceeding one thousand dollars per violation per day. Each and every such violation shall be a separate and distinct offense. Imposition of the civil penalty shall be subject to a hearing in conformance with chapter 34.05 RCW.
RCW 69.07.180 — Washington Code / Title 69 / Chapter 07 / Section 180
RCW 69.07.180: Bottled water labeling standards.
Status: in_force

All bottled water must conform to applicable federal and state labeling laws and be labeled in compliance with the following standards: (1) Mineral water may be labeled "mineral water." Bottled water to which minerals are added shall be labeled so as to disclose that minerals are added, and may not be labeled "natural mineral water." (2) Spring water may be labeled "spring water" or "natural spring water." (3) Water containing carbon dioxide that emerges from the source and is bottled directly with its entrapped gas or from which the gas is mechanically separated and later reintroduced at a level not higher than naturally occurring in the water may bear on its label the words "naturally carbonated" or "naturally sparkling." (4) Bottled water that contains carbon dioxide other than that naturally occurring in the source of the product shall be labeled with the words "carbonated," "carbonation added," or "sparkling" if the carbonation is obtained from a natural or manufactured source. (5) Well water may be labeled "well water" or "natural well water." (6) Artesian water may be labeled "artesian water" or "natural artesian water." (7) Purified water may be labeled "purified water" and the method of preparation shall be stated on the label, except that purified water produced by distillation may be labeled as "distilled water." (8) Drinking water may be labeled "drinking water." (9) The use of the word "spring," or any derivative of "spring" other than in a trademark, trade name, or company name, to describe water that is not spring water is prohibited. (10) A product meeting more than one of the definitions in RCW 69.07.170 may be identified by any of the applicable product types defined in RCW 69.07.170 , except where otherwise specifically prohibited. (11) Supplemental printed information and graphics may appear on the label but shall not imply properties of the product or preparation methods that are not factual.
RCW 69.04.050 — Washington Code / Title 69 / Chapter 04 / Section 050
RCW 69.04.050: Remedy by injunction.
Status: in_force

(1) In addition to the remedies hereinafter provided the director is hereby authorized to apply to the superior court of Thurston county for, and such court shall have jurisdiction upon prompt hearing and for cause shown to grant, a temporary or permanent injunction restraining any person from violating any provision of RCW 69.04.040 ; without proof that an adequate remedy at law does not exist. (2) Whenever it appears to the satisfaction of the court in the case of a newspaper, magazine, periodical, or other publication, published at regular intervals (a) that restraining the dissemination of a false advertisement in any particular issue of such publication would delay the delivery of such issue after the regular time therefor, and (b) that such delay would be due to the method by which the manufacture and distribution of such publication is customarily conducted by the publisher in accordance with sound business practice, and not to any method or device adopted for the evasion of this section or to prevent or delay the issuance of an injunction or restraining order with respect to such false advertisement or any other advertisement, the court shall exclude such issue from the operation of the restraining order or injunction.
RCW 69.28.133 — Washington Code / Title 69 / Chapter 28 / Section 133
RCW 69.28.133: Nonconforming honey—Sale or offer unlawful.
Status: in_force

It shall be unlawful for any person to sell, offer or intend for sale any honey which does not conform to the provisions of this chapter or any regulation promulgated by the director under this chapter.
RCW 69.50.440 — Washington Code / Title 69 / Chapter 50 / Section 440
RCW 69.50.440: Possession with intent to manufacture—Penalty.
Status: in_force

(1) It is unlawful for any person to possess ephedrine or any of its salts or isomers or salts of isomers, pseudoephedrine or any of its salts or isomers or salts of isomers, pressurized ammonia gas, or pressurized ammonia gas solution with intent to manufacture methamphetamine, including its salts, isomers, and salts of isomers. (2) Any person who violates this section is guilty of a class B felony and may be imprisoned for not more than ten years, fined not more than twenty-five thousand dollars, or both. Three thousand dollars of the fine may not be suspended. As collected, the first three thousand dollars of the fine must be deposited with the law enforcement agency having responsibility for cleanup of laboratories, sites, or substances used in the manufacture of the methamphetamine, including its salts, isomers, and salts of isomers. The fine moneys deposited with that law enforcement agency must be used for such clean-up cost.
RCW 69.25.930 — Washington Code / Title 69 / Chapter 25 / Section 930
RCW 69.25.930: Short title.
Status: in_force

This act may be known and cited as the "Washington wholesome eggs and egg products act".
RCW 69.07.900 — Washington Code / Title 69 / Chapter 07 / Section 900
RCW 69.07.900: Chapter is cumulative and nonexclusive.
Status: in_force

The provisions of this chapter shall be cumulative and nonexclusive and shall not affect any other remedy.
RCW 69.25.103 — Washington Code / Title 69 / Chapter 25 / Section 103
RCW 69.25.103: Eggs or egg products—In-state production—Associated commercial egg layer operation compliance with applicable standards.
Status: in_force

Any egg handler or dealer involved with the in-state production of eggs or egg products only intended for sale outside of the state of Washington must ensure that the associated commercial egg layer operation is in compliance with the applicable standards as provided in RCW 69.25.065 and 69.25.107 .
RCW 69.07.210 — Washington Code / Title 69 / Chapter 07 / Section 210
RCW 69.07.210: Cannabis-infused edible processing—Implementation.
Status: in_force

The department of agriculture, state liquor and cannabis board, and department of revenue shall take the necessary steps to ensure that RCW 69.07.200 is implemented on its effective date.
RCW 69.48.060 — Washington Code / Title 69 / Chapter 48 / Section 060
RCW 69.48.060: Collection system.
Status: in_force

(1)(a) At least one hundred twenty days prior to submitting a proposal under RCW 69.48.050 , a program operator must notify potential authorized collectors of the opportunity to serve as an authorized collector for the proposed drug take-back program. A program operator must commence good faith negotiations with a potential authorized collector no later than thirty days after the potential authorized collector expresses interest in participating in a proposed program. (b) A person or entity may serve as an authorized collector for a drug take-back program voluntarily or in exchange for compensation, but nothing in this chapter requires a person or entity to serve as an authorized collector. (c) A drug take-back program must include as an authorized collector any retail pharmacy, hospital or clinic with an on-site pharmacy, or law enforcement agency that offers to participate in the program without compensation and meets the requirements of subsection (2) of this section. Such a pharmacy, hospital, clinic, or law enforcement agency must be included as an authorized collector in the program no later than ninety days after receiving the offer to participate. (d) A drug take-back program may also locate collection sites at: (i) A long-term care facility where a pharmacy, or a hospital or clinic with an on-site pharmacy, operates a secure collection receptacle; (ii) A substance use disorder treatment program, as defined in RCW 71.24.025 ; or (iii) Any other authorized collector willing to participate as a collection site and able to meet the requirements of subsection (2) of this section. (2)(a) A collection site must accept all covered drugs from covered entities during the hours that the authorized collector is normally open for business with the public. (b) A collection site located at a long-term care facility may only accept covered drugs that are in the possession of individuals who reside or have resided at the facility. (c) A collection site must use secure collection receptacles in compliance with state and federal law, including any applicable on-site storage and collection standards adopted by rule pursuant to chapter 70A.205 or 70A.300 RCW and United States drug enforcement administration regulations. The program operator must provide a service schedule that meets the needs of each collection site to ensure that each secure collection receptacle is serviced as often as necessary to avoid reaching capacity and that collected covered drugs are transported to final disposal in a timely manner, including a process for additional prompt collection service upon notification from the collection site. Secure collection receptacle signage must prominently display a toll-free telephone number and website for the program so that members of the public may provide feedback on collection activities. (d) An authorized collector must comply with applicable provisions of chapters 70A.205 and 70A.300 RCW, including rules adopted pursuant to those chapters that establish collection and transportation standards, and federal laws and regulations governing the handling of covered drugs, including United States drug enforcement administration regulations. (3)(a) A drug take-back program's collection system must be safe, secure, and convenient on an ongoing, year-round basis and must provide equitable and reasonably convenient access for residents across the state. (b) In establishing and operating a collection system, a program operator must give preference to locating collection sites at retail pharmacies, hospitals or clinics with on-site pharmacies, and law enforcement agencies. (c)(i) Each population center must have a minimum of one collection site, plus one additional collection site for every fifty thousand residents of the city or town located within the population center. Collection sites must be geographically distributed to provide reasonably convenient and equitable access to all residents of the population center. (ii) On islands and in areas outside of population centers, a collection site must be located at the site of each potential authorized collector that is regularly open to the public, unless the program operator demonstrates to the satisfaction of the department that a potential authorized collector is unqualified or unwilling to participate in the drug take-back program, in accordance with the requirements of subsection (1) of this section. (iii) For purposes of this section, "population center" means a city or town and the unincorporated area within a ten-mile radius from the center of the city or town. (d) A program operator must establish mail-back distribution locations or hold periodic collection events to supplement service to any area of the state that is underserved by collection sites, as determined by the department, in consultation with the local health jurisdiction. The program operator, in consultation with the department, local law enforcement, the local health jurisdiction, and the local community, must determine the number and locations of mail-back distribution locations or the frequency and location of these collections events, to be held at least twice a year, unless otherwise determined through consultation with the local community. The program must arrange any periodic collection events in advance with local law enforcement agencies and conduct periodic collection events in compliance with United States drug enforcement administration regulations and protocols and applicable state laws. (e) Upon request, a drug take-back program must provide a mail-back program free of charge to covered entities and to retail pharmacies that offer to distribute prepaid, preaddressed mailing envelopes for the drug take-back program. A drug take-back program must permit covered entities to request prepaid, preaddressed mailing envelopes through the program's website, the program's toll-free telephone number, and a request to a pharmacist at a retail pharmacy distributing the program's mailing envelopes. (f) The program operator must provide alternative collection methods for any covered drugs, other than controlled substances, that cannot be accepted or commingled with other covered drugs in secure collection receptacles, through a mail-back program, or at periodic collection events, to the extent permissible under applicable state and federal laws. The department shall review and approve of any alternative collection methods prior to their implementation.
RCW 69.43.060 — Washington Code / Title 69 / Chapter 43 / Section 060
RCW 69.43.060: Theft—Missing quantity—Reporting.
Status: in_force

(1) The theft or loss of any substance under RCW 69.43.010 discovered by any person regulated by this chapter shall be reported to the pharmacy quality assurance commission within seven days after such discovery. (2) Any difference between the quantity of any substance under RCW 69.43.010 received and the quantity shipped shall be reported to the pharmacy quality assurance commission within seven days of the receipt of actual knowledge of the discrepancy. When applicable, any report made pursuant to this subsection shall also include the name of any common carrier or person who transported the substance and the date of shipment of the substance.
RCW 69.07.140 — Washington Code / Title 69 / Chapter 07 / Section 140
RCW 69.07.140: Violations—Warning notice.
Status: in_force

Nothing in this chapter shall be construed as requiring the department to report for prosecution violations of this chapter when it believes that the public interest will best be served by a suitable notice of warning in writing.
RCW 69.04.010 — Washington Code / Title 69 / Chapter 04 / Section 010
RCW 69.04.010: "Device."
Status: in_force

The term "device" (except when used in RCW 69.04.016 and in RCW * 69.04.040 (10), ** 69.04.270 , 69.04.690 , and in RCW 69.04.470 as used in the sentence "(as compared with other words, statements, designs, or devices, in the labeling)") means instruments, apparatus, and contrivances, including their components, parts and accessories, intended (1) for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in human beings or other animals; or (2) to affect the structure or any function of the body of human beings or other animals.
RCW 69.50.460 — Washington Code / Title 69 / Chapter 50 / Section 460
RCW 69.50.460: Cathinone or methcathinone—Unfair or deceptive practice under RCW 19.86.020.
Status: in_force

It is an unfair or deceptive practice under RCW 19.86.020 for any person or entity to distribute, dispense, manufacture, display for sale, offer for sale, attempt to sell, or sell to a purchaser any product that contains any amount of any cathinone or methcathinone as identified in RCW 69.50.204 (e) (3) and (5) [(5) (c) and (e)]. The legislature finds that practices covered by this section are matters vitally affecting the public interest for the purpose of applying the consumer protection act, chapter 19.86 RCW. Violations of this section are not reasonable in relation to the development and preservation of business.
RCW 69.51A.220 — Washington Code / Title 69 / Chapter 51A / Section 220
RCW 69.51A.220: Health care professionals may authorize medical use of cannabis—Qualifying patients under age eighteen.
Status: in_force

(1) Health care professionals may authorize the medical use of cannabis for qualifying patients who are under the age of eighteen if: (a) The minor's parent or guardian participates in the minor's treatment and agrees to the medical use of cannabis by the minor; and (b) The parent or guardian acts as the designated provider for the minor and has sole control over the minor's cannabis. (2) The minor may not grow plants or purchase cannabis-infused products, useable cannabis, or cannabis concentrates from a cannabis retailer with a medical cannabis endorsement. (3) Both the minor and the minor's parent or guardian who is acting as the designated provider must be entered in the medical cannabis authorization database and hold a recognition card. (4) A health care professional who authorizes the medical use of cannabis by a minor must do so as part of the course of treatment of the minor's terminal or debilitating medical condition. If authorizing a minor for the medical use of cannabis, the health care professional must: (a) Consult with other health care providers involved in the minor's treatment, as medically indicated, before authorization or reauthorization of the medical use of cannabis; and (b) Reexamine the minor at least once every six months or more frequently as medically indicated. The reexamination must: (i) Determine that the minor continues to have a terminal or debilitating medical condition and that the condition benefits from the medical use of cannabis; and (ii) Include a follow-up discussion with the minor's parent or guardian to ensure the parent or guardian continues to participate in the treatment of the minor.
RCW 69.25.200 — Washington Code / Title 69 / Chapter 25 / Section 200
RCW 69.25.200: Embargo—Petition for court order affirming—Removal of embargo or destruction or correction and release—Court costs, fees, administrative expenses—Bond may be required.
Status: in_force

When the director has embargoed any eggs or egg products, he or she shall petition the superior court of the county in which the eggs or egg products are located for an order affirming such embargo. Such court shall have jurisdiction for cause shown and after a prompt hearing to any claimant of eggs or egg products, shall issue an order which directs the removal of such embargo or the destruction or correction and release of such eggs and egg products. An order for destruction or the correction and release of such eggs and egg products shall contain such provision for the payment of pertinent court costs and fees and administrative expenses as is equitable and which the court deems appropriate in the circumstances. An order for correction and release may contain such provisions for a bond as the court finds indicated in the circumstance.
RCW 69.25.120 — Washington Code / Title 69 / Chapter 25 / Section 120
RCW 69.25.120: Director to cooperate with other agencies—May conduct examinations.
Status: in_force

The director shall, whenever he or she determines that it would effectuate the purposes of this chapter, cooperate with any state, federal, or other governmental agencies in carrying out any provisions of this chapter. In carrying out the provisions of this chapter, the director may conduct such examinations, investigations, and inspections as he or she determines practicable through any officer or employee of any such agency commissioned by him or her for such purpose.
RCW 69.50.4016 — Washington Code / Title 69 / Chapter 50 / Section 4016
RCW 69.50.4016: Provisions not applicable to offenses under RCW 69.50.410.
Status: in_force

RCW 69.50.401 through 69.50.4015 shall not apply to offenses defined and punishable under the provisions of RCW 69.50.410 .
RCW 69.41.240 — Washington Code / Title 69 / Chapter 41 / Section 240
RCW 69.41.240: Rules—Labeling and marking.
Status: in_force

The commission shall have authority to promulgate rules and regulations for the enforcement and implementation of RCW 69.41.050 and 69.41.200 through 69.41.260 .
RCW 69.36.060 — Washington Code / Title 69 / Chapter 36 / Section 060
RCW 69.36.060: Penalty.
Status: in_force

Any person violating the provisions of this chapter shall be guilty of a misdemeanor.
RCW 69.07.120 — Washington Code / Title 69 / Chapter 07 / Section 120
RCW 69.07.120: Disposition of money into food processing inspection account.
Status: in_force

All moneys received by the department under the provisions of this chapter, RCW 15.130.410 , and chapter 69.22 RCW shall be paid into the food processing inspection account hereby created within the agricultural local fund established in RCW 43.23.230 and shall be used solely to carry out the provisions of this chapter, RCW 15.130.410 , and chapters 69.22 and 15.130 RCW.
RCW 69.77.040 — Washington Code / Title 69 / Chapter 77 / Section 040
RCW 69.77.040: Patient eligibility for access and treatment with investigational product.
Status: in_force

A patient is eligible to request access to and be treated with an investigational product if: (1) The patient is eighteen years of age or older; (2) The patient is a resident of this state; (3) The patient's treating physician attests to the fact that the patient has a serious or immediately life-threatening disease or condition; (4) The patient acknowledges having been informed by the treating physician of all other treatment options currently approved by the United States food and drug administration; (5) The patient's treating physician recommends that the patient be treated with an investigational product; (6) The patient is unable to participate in a clinical trial for the investigational product because the patient's physician has contacted one or more clinical trials or researchers in the physician's practice area and has determined, using the physician's professional judgment, that there are no clinical trials reasonably available for the patient to participate in, that the patient would not qualify for a clinical trial, or that delay in waiting to join a clinical trial would risk further harm to the patient; and (7) In accordance with RCW 69.77.050 , the patient has provided written informed consent for the use of the investigational product, or, if the patient lacks the capacity to consent, the patient's legally authorized representative has provided written informed consent on behalf of the patient.
RCW 69.04.080 — Washington Code / Title 69 / Chapter 04 / Section 080
RCW 69.04.080: Avoidance of penalty.
Status: in_force

No person shall be subject to the penalties of RCW 69.04.060 : (1) For having violated RCW 69.04.040 (3), if he or she establishes that he or she received and sold such article in good faith, unless he or she refuses on request of the director to furnish the name and address of the person in the state of Washington from whom he or she received such article and copies of all available documents pertaining to his or her receipt thereof; or (2) For having violated RCW 69.04.040 (1), (3), or (4), if he or she establishes a guaranty or undertaking signed by, and containing the name and address of, the person in the state of Washington from whom he or she received such article in good faith, to the effect that such article complies with this chapter; or (3) For having violated RCW 69.04.040 (5), if he or she establishes a guaranty or undertaking signed by, and containing the name and address of, the person in the state of Washington from whom he or she received such advertisement in good faith, to the effect that such advertisement complies with this chapter; or (4) For having violated RCW 69.04.040 (9), if he or she establishes that he or she gave such guaranty or undertaking in good faith and in reliance on a guaranty or undertaking to him or her, which guaranty or undertaking was to the same effect and was signed by, and contained the name and address of, a person in the state of Washington.
RCW 69.43.048 — Washington Code / Title 69 / Chapter 43 / Section 048
RCW 69.43.048: Reporting and recordkeeping requirements—Submission of computer readable data, copies of federal reports.
Status: in_force

A manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes any substance specified in RCW 69.43.010 (1) and who is subject to the reporting or recordkeeping requirements of this chapter may satisfy the requirements by submitting to the pharmacy quality assurance commission, and its authorized representatives: (1) Computer readable data from which all of the required information may be readily derived; or (2) Copies of reports that are filed under federal law that contain all of the information required by the particular reporting or recordkeeping requirement of this chapter which it is submitted to satisfy.
RCW 69.25.180 — Washington Code / Title 69 / Chapter 25 / Section 180
RCW 69.25.180: Limiting entry of eggs and egg products into official plants.
Status: in_force

The director may limit the entry of eggs and egg products and other materials into official plants under such conditions as he or she may prescribe to assure that allowing the entry of such articles into such plants will be consistent with the purposes of this chapter.
RCW 69.06.060 — Washington Code / Title 69 / Chapter 06 / Section 060
RCW 69.06.060: Penalty.
Status: in_force

Any violation of the provisions of this chapter shall be a misdemeanor.
RCW 69.70.060 — Washington Code / Title 69 / Chapter 70 / Section 060
RCW 69.70.060: Form—Department to develop.
Status: in_force

The department shall develop a form for persons to use when releasing prescription drugs for distribution and certifying the condition of the drugs, as provided in RCW 69.70.020 (2).
RCW 69.50.470 — Washington Code / Title 69 / Chapter 50 / Section 470
RCW 69.50.470: Medication disposal, no penalty for compliance.
Status: in_force

It is not a violation of this chapter to possess or deliver a controlled substance in compliance with chapter 69.48 RCW.
RCW 69.43.100 — Washington Code / Title 69 / Chapter 43 / Section 100
RCW 69.43.100: Action by the commission against permit.
Status: in_force

In addition to any other grounds, the pharmacy quality assurance commission may take action against a permit issued under this chapter upon proof that: (1) The permit was procured through fraud, misrepresentation, or deceit; (2) The permittee has violated or has permitted any employee to violate any of the laws of this state relating to drugs, controlled substances, cosmetics, or nonprescription drugs, or has violated any of the rules and regulations of the pharmacy quality assurance commission.
RCW 69.50.327 — Washington Code / Title 69 / Chapter 50 / Section 327
RCW 69.50.327: Cannabis processors—Incorporation of characterizing flavor in vapor products.
Status: in_force

(1) Except as provided in subsection (2) of this section, cannabis processors may incorporate in cannabis vapor products a characterizing flavor if the characterizing flavor is derived from botanical terpenes naturally occurring in the cannabis plant, regardless of source, and if the characterizing flavor mimics the terpene profile found in a cannabis plant. Characterizing flavors authorized under this section do not include any synthetic terpenes. (2) If the board determines a characterizing flavor otherwise authorized under this section may pose a risk to public health or youth access, the board may, by rule adopted under RCW 69.50.342 , prohibit the use in cannabis vapor products of such a characterizing flavor.
RCW 69.41.260 — Washington Code / Title 69 / Chapter 41 / Section 260
RCW 69.41.260: Manufacture or distribution for resale—Requirements.
Status: in_force

All legend drugs manufactured or distributed for resale to any entity in this state other than the ultimate consumer shall meet the requirements of RCW 69.41.050 and 69.41.200 through 69.41.260 from a date eighteen months after June 12, 1980.
RCW 69.50.325 — Washington Code / Title 69 / Chapter 50 / Section 325
RCW 69.50.325: Cannabis producer's license, cannabis processor's license, cannabis retailer's license.
Status: in_force

*** CHANGE IN 2026 *** (SEE 2681.SL ) ***

*** CHANGE IN 2026 *** (SEE 1941.SL ) ***

(1) There shall be a cannabis producer's license regulated by the board and subject to annual renewal. The licensee is authorized to produce: (a) Cannabis for sale at wholesale to cannabis processors and other cannabis producers; (b) immature plants or clones and seeds for sale to cooperatives as described under RCW 69.51A.250 ; and (c) immature plants or clones and seeds for sale to qualifying patients and designated providers as provided under RCW 69.51A.310 . The production, possession, delivery, distribution, and sale of cannabis in accordance with the provisions of this chapter and the rules adopted to implement and enforce it, by a validly licensed cannabis producer, shall not be a criminal or civil offense under Washington state law. Every cannabis producer's license shall be issued in the name of the applicant, shall specify the location at which the cannabis producer intends to operate, which must be within the state of Washington, and the holder thereof shall not allow any other person to use the license. The application fee for a cannabis producer's license shall be two hundred fifty dollars. The annual fee for issuance and renewal of a cannabis producer's license shall be one thousand three hundred eighty-one dollars. A separate license shall be required for each location at which a cannabis producer intends to produce cannabis. (2) There shall be a cannabis processor's license to process, package, and label cannabis concentrates, useable cannabis, and cannabis-infused products for sale at wholesale to cannabis processors and cannabis retailers, regulated by the board and subject to annual renewal. The processing, packaging, possession, delivery, distribution, and sale of cannabis, useable cannabis, cannabis-infused products, and cannabis concentrates in accordance with the provisions of this chapter and chapter 69.51A RCW and the rules adopted to implement and enforce these chapters, by a validly licensed cannabis processor, shall not be a criminal or civil offense under Washington state law. Every cannabis processor's license shall be issued in the name of the applicant, shall specify the location at which the licensee intends to operate, which must be within the state of Washington, and the holder thereof shall not allow any other person to use the license. The application fee for a cannabis processor's license shall be two hundred fifty dollars. The annual fee for issuance and renewal of a cannabis processor's license shall be one thousand three hundred eighty-one dollars. A separate license shall be required for each location at which a cannabis processor intends to process cannabis. (3)(a) There shall be a cannabis retailer's license to sell cannabis concentrates, useable cannabis, and cannabis-infused products at retail in retail outlets, regulated by the board and subject to annual renewal. The possession, delivery, distribution, and sale of cannabis concentrates, useable cannabis, and cannabis-infused products in accordance with the provisions of this chapter and the rules adopted to implement and enforce it, by a validly licensed cannabis retailer, shall not be a criminal or civil offense under Washington state law. Every cannabis retailer's license shall be issued in the name of the applicant, shall specify the location of the retail outlet the licensee intends to operate, which must be within the state of Washington, and the holder thereof shall not allow any other person to use the license. The application fee for a cannabis retailer's license shall be two hundred fifty dollars. The annual fee for issuance and renewal of a cannabis retailer's license shall be one thousand three hundred eighty-one dollars. A separate license shall be required for each location at which a cannabis retailer intends to sell cannabis concentrates, useable cannabis, and cannabis-infused products. (b) An individual retail licensee and all other persons or entities with a financial or other ownership interest in the business operating under the license are limited, in the aggregate, to holding a collective total of not more than five retail cannabis licenses. (c)(i) A cannabis retailer's license is subject to forfeiture in accordance with rules adopted by the board pursuant to this section. (ii) The board shall adopt rules to establish a license forfeiture process for a licensed cannabis retailer that is not fully operational and open to the public within a specified period from the date of license issuance, as established by the board, subject to the following restrictions: (A) No cannabis retailer's license may be subject to forfeiture within the first nine months of license issuance; and (B) The board must require license forfeiture on or before twenty-four calendar months of license issuance if a cannabis retailer is not fully operational and open to the public, unless the board determines that circumstances out of the licensee's control are preventing the licensee from becoming fully operational and that, in the board's discretion, the circumstances warrant extending the forfeiture period beyond twenty-four calendar months. (iii) The board has discretion in adopting rules under this subsection (3)(c). (iv) This subsection (3)(c) applies to cannabis retailer's licenses issued before and after July 23, 2017. However, no license of a cannabis retailer that otherwise meets the conditions for license forfeiture established pursuant to this subsection (3)(c) may be subject to forfeiture within the first nine calendar months of July 23, 2017. (v) The board may not require license forfeiture if the licensee has been incapable of opening a fully operational retail cannabis business due to actions by the city, town, or county with jurisdiction over the licensee that include any of the following: (A) The adoption of a ban or moratorium that prohibits the opening of a retail cannabis business; or (B) The adoption of an ordinance or regulation related to zoning, business licensing, land use, or other regulatory measure that has the effect of preventing a licensee from receiving an occupancy permit from the jurisdiction or which otherwise prevents a licensed cannabis retailer from becoming operational. (d) The board may issue cannabis retailer licenses pursuant to this chapter and RCW 69.50.335 .
RCW 69.75.900 — Washington Code / Title 69 / Chapter 75 / Section 900
RCW 69.75.900: Effective date—2014 c 64.
Status: in_force

This act takes effect July 1, 2015.
RCW 69.41.020 — Washington Code / Title 69 / Chapter 41 / Section 020
RCW 69.41.020: Prohibited acts—Information not privileged communication.
Status: in_force

Legend drugs shall not be sold, delivered, dispensed or administered except in accordance with this chapter. (1) No person shall obtain or attempt to obtain a legend drug, or procure or attempt to procure the administration of a legend drug: (a) By fraud, deceit, misrepresentation, or subterfuge; or (b) By the forgery or alteration of a prescription or of any written order; or (c) By the concealment of a material fact; or (d) By the use of a false name or the giving of a false address. (2) Information communicated to a practitioner in an effort unlawfully to procure a legend drug, or unlawfully to procure the administration of any such drug, shall not be deemed a privileged communication. (3) No person shall willfully make a false statement in any prescription, order, report, or record, required by this chapter. (4) No person shall, for the purpose of obtaining a legend drug, falsely assume the title of, or represent himself or herself to be, a manufacturer, wholesaler, or any practitioner. (5) No person shall make or utter any false or forged prescription or other written order for legend drugs. (6) No person shall affix any false or forged label to a package or receptacle containing legend drugs. (7) No person shall willfully fail to maintain the records required by RCW 69.41.042 and * 69.41.270 . (8) A violation of this section is a class B felony punishable according to chapter 9A.20 RCW.
RCW 69.38.060 — Washington Code / Title 69 / Chapter 38 / Section 060
RCW 69.38.060: Manufacturers and sellers of poisons—License required—Penalty.
Status: in_force

The pharmacy quality assurance commission, after consulting with the department of health, shall require and provide for the annual licensure of every person now or hereafter engaged in manufacturing or selling poisons within this state. Upon a payment of a fee as set by the department, the department shall issue a license in such form as it may prescribe to such manufacturer or seller. Such license shall be displayed in a conspicuous place in such manufacturer's or seller's place of business for which it is issued. Any person manufacturing or selling poison within this state without a license is guilty of a misdemeanor.